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Zic3 plays essential roles in development and has been implicated in left-right 
patterning anomalies, cardiovascular malfunction and defects in skeletal and 
nervous system development. Affected cell types are primarily derived from the 
mesoderm and neuroectoderm. It was previously reported that Zic3 is required 
for pluripotency by repressing the endodermal lineage. To further our 
understanding of the molecular role of Zic3 in development, I sought to 
investigate (1) the transcriptional role of Zic3, (2) the genes directly regulated by 
Zic3, (3) the combinatorial interactions with other embryonic stem (ES) cell 
regulators in cell fate specification, and (4) role of Zic3 in cell-fate specification.  
 
My findings show that Zic3 is both a transcriptional activator and repressor, and it 
co-binds DNA with p300 for activation and Suz12 for repression. Zic3 directly 
activates genes involved in negative regulation of differentiation, early 
developmental genes involved in mesodermal and neuroectodermal lineage, 
while directly repressing genes involved in late differentiation. Zic3 co-occupies 
genes with other ES cell regulators in a lineage-specific fashion - Zic3 and core 
ES cell regulators co-bind genes involved in pluripotency; Zic3, Stat3 and E2f1 
co-bind genes involved in the haematopoietic system (mesoderm); Zic3, Nr5a2 
and Esrrb co-bind genes involved in the cardiovascular system and kidney 
development (mesoderm); Zic3 and Tcfcp2l1 co-bind genes involved in nervous 
system (neuroectoderm) and kidney development (mesoderm); Zic3 alone binds 
genes involved in the skeletal (mesoderm) and nervous system (neuroectoderm). 
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Further investigation of Zic3 in pluripotency and cell fate specification showed 
that Zic3 enhances the ES cell program, and directly activates Nanog, one of the 
core ES cell transcription factors. Similar to Nanog, Zic3 is required for germ cell 
migration. However, unlike Nanog but more similar to Oct4 and Sox2, the 
overexpression of Zic3 promotes cell fate specification. Overexpression of Zic3 
precludes endodermal specification, and enhances cardiomyocyte (mesodermal) 
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1.1. Zic3 in development 
1.1.1. Zic family and the Drosophila pair-rule gene, opa 
The mammalian Zinc finger protein of the cerebellum (Zic) family consists of five 
paralogous members (Zic1-5), and as their names suggest, they were first 
isolated from the mouse cerebellum. Zic3, the subject matter in this report, is one 
of the five members in this family. Members of the Zic family encode transcription 
factors. Each of these transcription factors composes five highly conserved 
tandem C2H2 zinc finger domains (Figure 1). These zinc finger domains are 
highly homologous to the zinc finger domains of the mammalian Gli family 
members which encode transcription factors of the hedgehog signaling pathway. 
Additionally, the zinc finger domains of the Zic family are highly homologous to 
the Drosophila pair-rule gene odd-paired (opa) (Aruga et al., 1996). Genes that 
are essential in development are usually highly conserved across evolution. In 
Drosophila, opa is involved in two distinct phases of development. In the earlier 
phase, opa is broadly transcribed in the ectoderm and mesoderm of the early 
embryo. Expression of opa then occurs intermittently during gastrulation with 
alternate bands of strong and weak expression. This establishes alternate 
parasegments. The expression of opa then ceases, with exception in a subset of 
neurogenic cells. Expression of opa is reactivated during a later phase, where it 
is involved in development of the visceral mesoderm (Benedyk et al., 1994; 
Cimbora and Sakonju, 1995). Even though there is no such comparable 
developmental process in vertebrates, Zic family members have been reported to 
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be essential in a broad spectrum of developmental processes, and mutations in 















Figure 1. Homology of zinc finger domains of mammalian Zic family members. Image adapted 
from Herman and Hodiri., 2002. 
 14 
1.1.2. Human developmental disorders associated with Zic3 mutation or 
deficiency 
Various human disorders have been associated with mutations of ZIC3. 
Numerous reports have shown that mutation or deletion of ZIC3 results primarily 
in laterality defects or visceral situs abnormalities, cardiovascular malfunctions, 
neural tube defects and cerebellar hypoplasia (Casey et al., 1993; Chung et al., 
2011; D'Alessandro et al., 2011; De Luca et al., 2010; Ferrero et al., 1997; Fritz 
et al., 2005; Gebbia et al., 1997; Megarbane et al., 2000; Tzschach et al., 2006; 
Ware et al., 2004). ZIC3 is the first gene to be implicated in human situs 
anomalies, and is one of the only few known monogenic causes of congenital 
heart diseases which are known to have a multi-factorial etiology. Human situs 
abnormalities include situs ambiguous or heterotaxy which exhibits randomised 
placement of organs position, and situs inversus which exhibits mirror-image 
reversal of organs position. Due to the fact that mammalian Zic3 is localized on 
the X chromosome, males carrying ZIC3 mutations manifest more severe 
anomalies than heterozygous females carrying ZIC3 mutations. ZIC3 mutations 
account for majority of X-linked heterotaxy and 1% of sporadic heterotaxy (Ware 
et al., 2004). Although situs inversus rarely poses any clinical risk, heterotaxy 
manifests as multiple congenital abnormalities such as complex congenital heart 
defects, altered lung lobation, asplenia, gastrointestinal malrotation, biliary 
system abnormalities and lumbosacral spinal abnormalities. Congenital heart 
disease is the most common cause of infant mortality and requires surgical 
intervention to prevent fatality. Apart from the complex congenital heart defects 
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associated with heterotaxy, isolated congenital heart defects independent of 
heterotaxy have also been reported with ZIC3 mutation (Chung et al., 2011; 
Megarbane et al., 2000; Ware et al., 2004). Recently, a novel ZIC3 alternatively-
spliced isoform was discovered (Bedard et al., 2011). In mice, depletion of both 
isoforms results in severe gastrulation defects and embryonic lethality 
(Purandare et al., 2002; Ware et al., 2006a). It remains possible that mutation in 
the novel isoform in human may result in embryonic lethality. 
 
1.1.3. Expression pattern of Zic3 in vertebrates 
The expression of opa in Drosophila may not be directly relatable to that of the 
Zic family members in vertebrates due to the lack of a comparable 
developmental process in the latter. However, there are some similarities that 
can be drawn from the expression of opa and Zic3, and that is their expression in 
the embryonic ectoderm and mesoderm (Figure 2).  
 
In Xenopus, zic3 expression occurs during the onset of gastrulation. Expression 
is initiated in the involuting mesoderm and the ectoderm (Figure 3). Expression in 
the ectoderm then extends anteriorly into the prospective neural plate while 
diminishing in the midline of the neural plate. At this stage, zic3 expression 
preceeds that of proneural genes. Expression persists in the neural plate, and 
continues into the neural tube, and eventually into the developing mid- and 
hindbrain. In the early tadpoles, zic3 is expressed in the dorsal telencephalon, 
rhombencephalon and in the tailbud (Kitaguchi et al., 2002; Nakata et al., 1997).  
 16 
In zebrafish, zic3 expression occurs in the mesendoderm and the ectoderm 
(Figure 4). In contrast to Xenopus, ectodermal zic3 expression in zebrafish does 
not only occur in the prospective neural plate but also in the posterior dorsal 
ectoderm. Expression then continues into the dorsal regions of the brain and the 
tailbud, and eventually in the telencephalon, diencephalon and mesencephalon 
(Grinblat and Sive, 2001).  
 
In mouse, Zic3 expression occurs in the mesoderm during the onset of 
gastrulation, primarily in the caudal primitive streak (Figure 5). Expression then 
occurs in the neural plate, and extends into the dorsal neural tube, tailbud and 
somites. Subsequently, expression is restricted to the dorsal regions of the brain, 
spinal cord, limb bud and neural retina. In the adult, Zic3 expression is restricted 
to the cerebellum (Nagai et al., 1997).  
 
There are two striking conserved features of Zic3 expression during gastrulation 
across these species, and they are the expression of Zic3 in the embryonic 
mesoderm and the prospective neuroectoderm.  The neuroectoderm gives rise to 
the neural plate which subsequently folds to form the neural tube. Zic3 
expression is generally restricted to derivatives of the dorsal neural tube, namely 



















Figure 2. Expression of opa in Drosophila embryos. (A) Broad expression in mesoderm and 
ectoderm. (B) Expression restricted to alternate parasegments. (C) Expression restricted to 
neurogenic cells. (D) Dorsal image of C. Image adapted from Cimbora and Sakonju., 1995. 
Figure 3. Expression of zic3 in Xenopus embryos. (A) Expression in the prospective neural 
plate (NP) and involuting mesoderm at the blastolip (BL) in the early gastrula. (B) Expression 
continues in the prospective neural plate (NP) in the mid gastrula. (C) Expression restricted to 
the neural fold (NF) and the hindbrain (HB) in the late gastrula. (D) Expression was eventually 
restricted to the brain (B), spinal cord (SC) and tailbud (TB). Image adapted from Cimbora and 
Sakonju., 1995. 
A D C B 
Figure 4. Expression of zic3 in zebrafish embryos. (A) Expression in ectoderm and 
mesendoderm in the early gastrula. (B) Expression continues in the mid gastrula. (C) 
Expression restricted to the neural fold and the hindbrain in the late gastrula. (D) Expression 
restricted to the presumptive brain. (D) Expression was eventually restricted to the brain (B), 











Figure 5. Expression of Zic3 in mouse embryos. (A-C) At the primitive streak stage, Zic3 is 
expressed in the ectoderm and mesoderm. (D-F) Later in development, Zic3 expression is 









1.1.4. Functional analysis of Zic3 in Xenopus and zebrafish 
Extensive functional studies of Zic3 have been done in Xenopus, zebrafish and 
mouse. Overexpression of zic3 in Xenopus induces expression of proneural 
genes and expands the neuroectoderm. Overexpression of BMP 
antagonist/neural inducer, noggin, extends the expression of zic3 while 
overexpression of BMP immediate-early response protein, msx1, or anti-neural 
gene, dlx3, inhibits zic3 and thus blocks neuralisation (Feledy et al., 1999; 
Nakata et al., 1997; Suzuki et al., 1997; Yamamoto et al., 2000). In zebrafish, 
loss of function of BMP antagonist/neural inducer, chordino, results in 
downregulation of zic3. This advocates that BMP inhibits the expression of zic3 
(Grinblat and Sive, 2001). Expression of zic3 is also upregulated by calcium-
induced xPRMT1b in the Xenopus neuroectoderm (Batut et al., 2005), and 
homeodomain transcription factor, Xmeis1, which is expressed in the neural folds 
(Maeda et al., 2001). More recently, it was shown in Xenopus that inhibition of 
FGF4 signaling suppresses zic3 expression (Marchal et al., 2009).  
 
Unilateral misexpression of zic3 in Xenopus also causes defects in heart and gut 
looping. Normal expression of zic3 is symmetric and the right-sided 
misexpression of zic3 reverses heart and gut looping. This was observed with 
aberrant right-sided expression of xnr1 and pitx2 which are normally expressed 
in the left lateral plate mesoderm (Kitaguchi et al., 2000). Mesodermal expression 
of zic3 is initiated by brachyury which has also been implicated in left-right 
patterning (Kitaguchi et al., 2002).  
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1.1.5. Functional analysis of Zic3 in mouse 
Mutation and deletion of Zic3 in mice exhibit similar phenotypes to that of human 
but encompass a wider phenotypic variation.  The spontaneous X-linked mouse 
Bent tail is a well-studied model that harbours a Zic3 deletion (Carrel et al., 2000; 
Klootwijk et al., 2000; Klootwijk et al., 2004). A wide array of anomalies has been 
observed in this model. Similar to humans, hemizygous males exhibit more 
severe phenotypes than females. Situs anomalies and neural tube defects 
including exencephaly and the characteristic bent tail were observed in these 
mice. These mice also exhibit reduced viability and fertility. In a separate Zic3-
null mice model, 50% of the null mice are embryonic lethal with an additional 
30% of perinatal lethality. The embryonic lethal Zic3-null embryos exhibit 
gastrulation defects, defective mesoderm formation, situs anomalies, severe 
congenital heart defects and defective neural tube closure. The live born Zic3-
null mice exhibit situs anomalies, cardiovascular malfunctions, central nervous 
system defects such as ancephaly and spina bifida, tail defect, and axial skeletal 
anomalies (Purandare et al., 2002; Ware et al., 2006b). The molecular 
mechanism underlying the involvement of Zic3 in laterality and neural tube 
defects in mammalians remains to be investigated. However, it has been shown 
that mutation or deficiency in Zic3 results in aberrant Nodal expression 
(Purandare et al., 2002; Ware et al., 2006a). Other biochemical analyses of ZIC3 
have suggested that all known point mutations occur either in the DNA binding 
domain, or the N-terminal domain which contains the nuclear localization signal. 
As such, the pathogenesis of ZIC3 mutations is largely due to the failure of 
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transactivation or aberrant nuclear/cytoplasmic localization (Ware et al., 2004). 





1.2. Zic3 in embryonic stem cells 
1.2.1. Brief background on embryonic stem cells 
Embryonic stem (ES) cells are cells derived from the inner cell mass of embryo 
blastocysts (Evans and Kaufman, 1981; Martin, 1981). Two characteristic 
hallmarks of ES cells are their ability to (1) self-renew indefinitely and (2) 
differentiate into cells of the embryo proper. Mouse ES cells are capable of 
recapitulating full developmental potential when injected into mouse blastocysts, 
generating the ectoderm, mesoderm, endoderm and germ cells (Figure 6). ES 
cells have unlimited proliferation potential and these cells maintain their 
pluripotency via molecular signaling pathways which will be described in the 
following section. ES cells are therefore great tools for studying development, 
directed differentiation, therapeutic applications and regenerative medicine. 
 
Figure 6. Pluripotent embryonic stem cells are derived from the inner cell mass of the blastocyst. 
These cells divide indefinitely in vitro and differentiates into ectoderm, mesoderm, endoderm and 




1.2.2. External signalling in the maintenance of pluripotency 
The self-renewing capacity of mouse ES cells was previously possible only in the 
presence of inactivated mouse embryonic feeder cells and serum. It was 
discovered that LIF, an interleukin 6 cytokine, is the trophic factor provided by the 
feeder cells. LIF sustains the self-renewing capacity of mouse ES cells in the 
absence of feeder cells (Smith et al., 1988; Williams et al., 1988). LIF binds the 
membrane-bound gp130 which eventually activates Stat3. Overexpression of 
Stat3 has been able to maintain ES cells in the pluripotent state in the absence of 
LIF (Boeuf et al., 1997) whereas repression of Stat3 promotes spontaneous 
differentiation (Raz et al., 1999). However, LIF in the absence of serum is unable 
to sustain the pluripotent state. It was later discovered that the serum factor that 
was required was BMP. BMP induces the expression of Id genes via Smad1. 
Overexpression of Id negates the requirement for serum to permit self-renewal in 
the presence of LIF alone (Ying et al., 2003a).  
 
 
1.2.3. Intrinsic transcriptional regulatory network in ES cells 
In addition to the external signalling, the pluripotent state of ES cells is governed 
by a complex regulatory network composed of a myriad of ES cell regulators. 
The master regulators of ES cells are the transcription factors Oct4, Sox2 and 
Nanog. This transcription factor trio forms the core of the complex ES regulatory 
network and choreographs pluripotency by (1) positively regulating their own 
promoters, (2) feed-forward and (3) feedback interactions, thereby forming an 
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interconnected autoregulatory loop (Boyer et al., 2005; Loh et al., 2006). 
Genome-wide mapping of these core transcription factors has shown that they 
(1) activate genes that encode ES cell regulators, and together they maintain the 
ES cell pluripotent state while (2) repressing genes that encode lineage-specific 
transcription factors (Figure 7) (Boyer et al., 2005; Loh et al., 2006). Therefore, 
loss of any of these core transcription factors will result in a loss of the ES cell 
pluripotent state. For instance, depletion of Oct4 or Sox2 in ES cells results in 
formation of cells of the trophectodermal lineage (Masui et al., 2007; Nichols et 
al., 1998; Niwa et al., 2000) while depletion of Nanog generates the 
extraembryonic endoderm (Mitsui et al., 2003). Deficiency of any of these core 
transcription factors in mice would result in embryonic lethality (Avilion et al., 
2003; Kehler et al., 2004; Mitsui et al., 2003). Strikingly, overexpression of Oct4 
and Sox2 does not maintain pluripotency. Instead overexpression of Oct4 in ES 
cells drives differentiation towards primitive endoderm (Niwa et al., 2000), and 
overexpression of Sox2 drives differentiation towards neurectoderm, mesoderm 
and trophectoderm (Kopp et al., 2008). The overexpression of Nanog, however, 
has been able to maintain the ES cell pluripotent state in the absence of LIF via 
the activation of Stat3 (Chambers et al., 2003; Mitsui et al., 2003). 
 
Conversion of somatic cells into induced pluripotent stem cells has been possible 
through ectopic expression of two of these core transcription factors, Oct4 and 
Sox2, together with Klf4 and c-Myc (Takahashi and Yamanaka, 2006). Klf4 and 
its closely related family members, Klf2 and Klf5, have been shown to be 
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required for mouse ES cells self-renewal (Jiang et al., 2008). Similar to Nanog, 
overexpression of Klf2, -4 or -5 negates the requirement for LIF, acting via the 
LIF-Stat3 pathway to enhance pluripotency. c-Myc, a regulator of transcriptional 
elongation in ES cells (Rahl et al., 2010), acts downstream of the LIF-Stat3 
pathway (Cartwright et al., 2005). Together, the forced expression of Oct4, Sox2, 
Klf4 and c-Myc reprograms somatic cells into induced pluripotent stem cells via 
activation of the endogenous core transcription factors Oct4, Sox2 and Nanog. 
This then initiates the positive-feedback loop that sustains their expression and 
activates the ES cell program (Jaenisch and Young, 2008).    
 
The ES cell program also constitutes other ES cell regulators that collaborate 
with the core transcription factors and the external signalling pathway (Table 1). 
In addition to the aforementioned transcription factors (Oct4, Sox2, Nanog, Klf4, 
c-Myc, Stat3, Smad1), other ES cell regulators have been shown to be 
preferentially expressed in ES cells and are implicated in the ES cell program. 
Together, these transcription factors co-occupy genomic loci forming multiple 
transcription factor-binding modules (Chen et al., 2008; Kim et al., 2008). These 
multiple transcription factor-binding loci (MTL) are generally enhancers. 
Therefore, the enhancers bound by these transcription factors form 
enhanceosomes. These enhanceosomes promote synergistic and combinatorial 
effects of multiple ES cell regulators on transcriptional regulation to maintain the 
ES cell program. Genome-wide mapping of several of these ES cell regulators 
showed that these regulators can be grouped into two distinct clusters, the Oct4-
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centric module and the Myc-centric module (Figure 8). The Oct4-centric module 
consists of ES regulators Oct4, Sox2, Nanog, Stat3, Smad1, Klf4, Esrrb, Dax1, 
Tcf3, Zfp281 and Tcfcp2l1 whereas the Myc-centric module consists of c-Myc, n-
Myc, E2f1, Zfx, Ronin, Rex1 and CTCF (Chen et al., 2008; Kim et al., 2008). The 
Oct4-centric module exhibits characteristic ES cell-specific enhancer activity 
whereas the Myc-centric module is primarily involved in housekeeping activities 
such as cellular metabolism, cell cycle, translation and splicing, to sustain the 
high proliferative capacities of ES cells (Chen et al., 2008; Kim et al., 2008). Both 
modules work hand-in-hand to orchestrate the ES cell program. 
 
Figure 7. The embryonic stem cell program. This program is driven by the core ES cell 
transcription factors Oct4, Sox2 and Nanog. Together, they activate pluripotency genes and 




Figure 8. The Oct4-centric and Myc-centric modules of the embryonic stem cell program. The 
Oct4-centric module binds enhancers of genes that maintain pluripotency whereas the Myc-
centric module binds metabolism and proliferation genes to promote self-renewal. Image 





Factors Function (Reference) 
Oct4-centric module 
Oct4 Pluripotency (1,2); Core transcription factor (3,4); Reprogramming (5) 
Sox2 Pluripotency (6); Core transcription factor (3); Reprogramming (5) 
Nanog Pluripotency (7); Core transcription factor (3,4) 
Stat3 LIF signalling (8) 
Smad1 BMP signaling (9) 
Klf4 ES-self renewal (10); Reprogramming (5) 
Esrrb Steriod hormone receptor implicated in reprogramming (11) 
Tcfcp2l1 Preferentially expressed in ES cells (12) 
Tcf3 Wnt signalling for pluripotency (13)  
Dax1 Pluripotency (14) 
Zfp281 Pluripotency (15) 
  
Myc-centric module 
c-Myc Proliferation (16,17); Reprogramming (5) 
n-Myc Functionally replaces c-Myc (18)  
E2f1 Cell cycle progression (19) 
Zfx Self-renewal (20) 
CTCF Transcriptional insulation (21) 
Rex1 Preferentially expressed in ES cells (22) 
  
Other known ES cell regulators 
Nr5a2 Reprogramming (23) 
Eset1 Represses extraembryonic trophoblast gene expression in ES cells (24) 
Zfp206 Pluripotency (25) 
Rest Represses neural genes expression in ES cells (26) 
  
Transcriptional Coregulators 
p300 Transcriptional coactivator (27) 
Suz12 Polycomb group of transcription corepressor (28) 
Ezh2 Polycomb group of transcription corepressor (29) 
Ring1B Polycomb group of transcription corepressor (30) 
Sin3a Chromatin remodeling complex for transcriptional repression (31) 
  
Histone marks 
H3K4me1 Associated with promoters and enhancers (32,33) 
H3K4me3 Associated with activation (32,33) 
H3K27me3 Associated with repression (32,33) 
 
References: 1(Nichols et al., 1998); 2(Niwa et al., 2000); 3(Boyer et al., 2005); 4(Loh et al., 2006); 
5(Takahashi and Yamanaka, 2006); 6(Avilion et al., 2003); 7(Chambers et al., 2003); 8(Boeuf et 
al., 1997); 9(Ying et al., 2003a); 10(Jiang et al., 2008); 11(Feng et al., 2009); 12(Ivanova et al., 
2006); 13(Cole et al., 2008); 14(Khalfallah et al., 2009); 15(Wang et al., 2008); 16(Rahl et al., 
2010); 17(Cartwright et al., 2005); 18(Malynn et al., 2000); 19(Bieda et al., 2006); 20(Galan-
Caridad et al., 2007); 21(Kim et al., 2007); 22(Ben-Shushan et al., 1998); 23(Heng et al., 2010); 
24(Yuan et al., 2009); 25(Wang et al., 2007); 26(Chen et al., 1998); 27(Chen et al., 2008); 
28(Pasini et al., 2007); 29(O'Carroll et al., 2001); 30(Leeb and Wutz, 2007); 31(Cowley et al., 
2005); 32(Bernstein et al., 2006); 33(Rada-Iglesias et al., 2011).  
 
Table 1. Examples of transcription factors, transcription coregulators, and histone 
modifications implicated in the ES cell program. 
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1.2.4. Zic3 in the embryonic stem cell program 
Our lab has previously shown that Zic3 is a downstream binding target of the 
core transcription factors Oct4, Sox2 and Nanog (Lim et al., 2007). In addition, 
our lab showed that expression of Zic3 is similar to that of the core transcription 
factors. Like the core transcription factors, Zic3 is preferentially expressed in ES 
cells and is downregulated upon induction of differentiation such as LIF 
withdrawal. Depletion of Zic3 results in spontaneous differentiation, thus 
indicating that Zic3 is required for maintenance of pluripotency. On further 
investigation, depletion of Zic3 results in an upregulation of endodermal markers. 




1.3. Rationale of this study 
Zic3 has been implicated in various developmental defects. Reoccurring defects 
that are observed in mammalians include left-right patterning anomalies, 
cardiovascular malfunction, and defects in skeletal and nervous system 
development. However, the molecular mechanism behind its diverse role has 
hitherto not been investigated in mammalians. Expression analysis in mice has 
demonstrated that Zic3 is expressed in embryonic mesoderm and ectoderm. The 
majority of the cells implicated in the reported developmental defects are derived 
from mesoderm and ectoderm. ES cells are great tools for the study of 
differentiation and understanding developmental disorders, and our lab has 
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previously demonstrated the importance of Zic3 in maintaining the ES cell 
pluripotent state. However, how Zic3 integrates with the ES cell regulators in the 
ES cell program has hitherto not been examined. In addition, our lab showed that 
Zic3 represses the endodermal lineage. This raised the hypothesis that Zic3 is a 
regulator of meso-ectodermal cell fate specification. Therefore, to further our 
understanding of the molecular role of Zic3 in development, I sought to 
investigate (1) the transcriptional role of Zic3, (2) the genes directly regulated by 
Zic3, (3) the combinatorial interaction with other ES cell regulators in cell fate 

















CHAPTER 2:  
ZIC3 REGULATORY NETWORK  






Zic3 has been shown to be required for the maintenance of the ES cell 
pluripotent state (Lim et al., 2007). The analysis of gene regulatory networks by 
global “omics” techniques is a useful methodology that allows us to identify 
genes that are directly regulated by transcription factors, thus dissecting 
molecular mechanisms to better understand the role of the transcription factors. 
In order to comprehend the transcriptional role as well as to identify the 
downstream targets of Zic3 that maintain the pluripotent state of ES cells, I took a 
genomic approach and assayed for global Zic3 binding sites in mouse ES cells 
by chromatin immunoprecipitation (ChIP) coupled with massively parallel short-
tag-based sequencing (seq) in E14 mouse ES cells. In this chapter, I report that 
Zic3 occupancy is equally distributed between promoter and enhancer regions. 
Coupled with the gene expression profile of Zic3 that was previously generated in 
the lab, I show that Zic3 directly activates genes involved in negative regulation 
of differentiation, mesodermal morphogenesis, early nervous system 
development, early skeletal system development and early reproductive system 
development. Zic3 directly represses genes involved in late nervous system 
development, late cardiovascular development and late reproductive system 
development. Zic3 co-activates genes with Nr5a2, Nanog, Oct4, Sox2, Smad1 
and Stat3 via DNA-co-binding with p300, and represses genes via DNA-co-





2.2.1. Binding distribution of Zic3 suggests a broad regulation of genes 
A total of 15.7 million and 12.9 million tags were obtained from Zic3-ChIP and the 
input, respectively. Zic3 binding peaks were called using the algorithm, MACS. A 
total of 21,663 binding peaks were identified and mapped to the mouse genome. 
Out of which, 7568 peaks were mapped to promoter regions (35%), 8279 peaks 
were mapped to intergenic regions (38%), and 5816 peaks were mapped to 
intragenic regions (27%) (Figure 9A). Zic3 binding were validated by ChIP 
coupled with quantitative PCR (Figure 10). Extensive studies have been done on 
identifying transcription factors involved in regulating the ES cell pluripotent state. 
I compared the binding distribution of Zic3 to that of some known ES cell 
regulators implicated in the ES cell program - Oct4, Nanog, Sox2, Stat3, Smad1, 
Esrrb and Klf4. Oct4, Nanog, Sox2, Esrrb and Nr5a2 are known regulators of 
pluripotency and/or self-renewal (Avilion et al., 2003; Chambers et al., 2003; Guo 
and Smith, 2010; Nichols et al., 1998; Zhang et al., 2008a). Smad1 and Stat3 are 
key components of the BMP and LIF signalling pathways, respectively (Nichols et 
al., 1998; Niwa et al., 2000). Oct4, Sox2, Esrrb, Klf4 and Nr5a2 have been 
implicated in reprogramming (Feng et al., 2009; Heng et al., 2010; Jiang et al., 
2008; Takahashi and Yamanaka, 2006). Based on the profile of their binding 
distributions, these transcription factors were classified into two distinct groups. 
Nanog, Sox2, Smad1 and Nr5a2 were classified into GROUP I which exhibited 
more binding in the intergenic regions, which are associated with enhancers, 
compared to promoters (Figure 9B). On the other hand, Oct4, Stat3, Esrrb and 
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Klf4 were classified into GROUP II which exhibited equal or more binding in 
promoters compared to the intergenic regions (Figure 9B). Zic3 exhibited a 
binding distribution similar to transcription factors in GROUP II (Figure 9B). 
GROUP I binding profile suggested a more enhancer-based regulation which is 
associated with a more cell type-specific transcriptional regulation whereas 
GROUP II suggested a broader function based on regulation of both promoters 




















Figure 9. Genome-wide binding distribution of ES cell regulators in mouse embryonic stem 
cells based on chromatin immunoprecipitation. Binding distribution of (A) Zic3 and (B) 
Nanog, Sox2, Smad1, Nr5a2, Oct4, Stat3, Esrrb and Klf4. Binding distributions were 
separated into two groups. Group I binding occurred more frequently in the intergenic regions 
than in promoters whereas Group II binding occurred equally or more frequently in promoters 
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Figure 10. Validation of Zic3-binding targets. Several binding targets identified from Zic3-
ChIP-seq were selected (Agtrap, DIIert, DLL, Fgf5, Jarid2 and Klf6) for validation. IgG-ChIP 
was used as a negative control. Zic3-ChIP and IgG-ChIP purified DNA were subjected to 
quantitative PCR. See Table 5 for sequence of primers. Each experiment was performed 




2.2.2. Zic3 directly regulates genes that are involved in various 
developmental processes. 
Our lab previously generated Zic3-knockdown cells and performed microarray 
analysis on these cells (Lim, 2008). I compared the Zic3-ChIP binding data to the 
microarray analysis to identify genes that were either up- or downregulated upon 
Zic3 knockdown, and are located within 20 kb of Zic3 binding peaks. These 
would therefore represent genes that were likely directly regulated by Zic3. 203 
out of 292 genes that were downregulated upon Zic3 knockdown were bound by 
Zic3 (Zic3-KD-down). These genes are therefore representative of Zic3-directly 
activated genes (Figure 11). 167 out of the 238 genes that were upregulated 
upon Zic3 knockdown were bound by Zic3 (Zic3-KD-up). These genes are 
therefore representative of Zic3-directly repressed genes (Figure 11). Both lists 
of Zic3-directly activated genes and Zic3-directly repressed genes were uploaded 
to GREAT for Gene Onthology (GO) analysis (http://great.stanford.edu/). GO 
analysis of Zic3-directly activated genes enriched for the following biological 
processes: negative regulation of differentiation, mesodermal morphogenesis, 
early nervous system development, early skeletal system development, and early 
reproductive system development (Figure 11). GO analysis of Zic3-directly 
repressed genes enriched for biological processes involved in late nervous 
system development, late cardiovascular development, and late reproductive 
system development (Figure 11). 
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Figure 11. Model of Zic3 directly regulated genes based on GREAT Gene Onthology analysis. 
Analysis was performed on genes downregulated or upregulated upon Zic3 depletion in mouse 
ES cells, and are located within 20kb of the Zic3 binding peaks generated from the chromatin 
immunoprecipitation of Zic3 in mouse ES cells. 
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2.2.3. p300 occupies Zic3-directly activated genes whereas Suz12 occupies 
Zic3-directly repressed genes  
I have shown that Zic3 is both a transcriptional activator and repressor. Next, I 
sought to understand the mechanism underlying Zic3 transcriptional activation 
and repression. Studies have reported that ES cell regulators co-occupy genomic 
loci which are largely enhancers (Chen et al., 2008; Kim et al., 2008). p300 is a 
transcription coactivator commonly found recruited to these enhancers. 
Recruitment of p300 to genomic sites is dependent on Oct4, Sox2 and Nanog, as 
their depletion led to reduction in p300 binding. Recruitment of p300 is crucial for 
subsequent recruitment of the transcriptional machinery (Conaway et al., 2005; 
Malik and Roeder, 2005; Roeder, 1998; Taatjes, 2010). Suz12 on the other hand, 
is a Polycomb group (PcG) protein, and together with other PcG proteins, the 
complex functions as a chromatin regulator required for repression of lineage-
specific regulators (Bilodeau et al., 2009; Margueron et al., 2009; Yeap et al., 
2009; Yuan et al., 2009). I examined whether ES cell-specific transcription 
factors (Oct4, Sox2, Nanog, Stat3, Smad1, Klf4, Esrrb, Nr5a2, E2f1, Tcfcp2l1, 
REST, c-Myc, n-Myc and Zfx – functions denoted in Table1) and transcriptional 
co-regulators, p300 and Suz12, occurred at Zic3-directly activated genes or Zic3-
directly repressed genes. The normalized ratio of the number of genes that were 
directly activated by Zic3 (Zic3-KD-down) versus those directly repressed by Zic3 
(Zic3-KD-up), and were within 20kb of the binding peaks of transcription factors 
was obtained. It was observed that Klf4, Esrrb, Tcfcp2l1, E2f1, REST, c-Myc, n-
Myc and Zfx (ratio<2 but >1) co-occupied both Zic3-directly activated and 
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repressed genes (Figure 12), suggesting that these regulators do not mediate 
Zic3-driven transcription regulation. On the other hand, Nr5a2, Nanog, Oct4, 
Sox2, Smad1 and Stat3 co-occupied genes that are bound and activated by Zic3 
(ratio ≥ 2) (Figure 12). Interestingly, transcriptional coactivator p300 also co-
occurred with these transcription factors. This suggested that Zic3 may co-bind 
genes with Nr5a2, Nanog, Oct4, Sox2, Smad1 and Stat3 to orchestrate 
transcriptional activation via recruitment of p300. Additionally, Suz12 co-occurred 
with Zic3 at Zic3-repressed genes. Therefore, suggesting that Zic3 may recruit 
Suz12 for transcriptional repression.  
Figure 12. Ratio of number of genes directly activated by Zic3 versus repressed by Zic3, 








Zic3 has been implicated in a wide-array of developmental processes. However, 
the underlying mechanism has hitherto not been elucidated. Analysis of the 
occupancy of Zic3 in the genome suggests that Zic3 has a binding distribution 
that is more similar to Oct4, Stat3, Klf4 and Esrrb (Group II), rather than Nanog, 
Sox2, Smad1 and Nr5a2 (Group I) (Figure 9B). Nanog, Sox2, Smad1 and Nr5a2 
have binding distributions that exhibit more binding in enhancers compared to 
promoters. Oct4, Stat3, Klf4 and Esrrb have binding distributions that exhibit 
lesser or equal binding in enhancers compared to promoters. Enhancer-based 
gene regulation has been associated with cell-type specific regulation whereas 
promoter-based gene regulation is broader. Group I binding distribution suggests 
a more cell-type specific gene regulation whereas Group II binding distribution 
suggests a broader gene regulation. Zic3 falls into Group II, and this accounts for 
the ability of Zic3 to function as a regulator in a wide-spectrum of developmental 
processes including left-right patterning, cardiovascular system, skeletal system 
and central nervous system development.   
 
To further our understanding of the diverse developmental role of Zic3, I 
identified genes that are directly regulated by Zic3. A total of 203 genes are 
directly activated by Zic3 (Zic3-KD-down) whereas 167 genes are directly 
repressed by Zic3 (Zic3-KD-up) (Figure 11). Approximately 70% of genes that 
are up- or downregulated upon depletion of Zic3 are directly bound by Zic3. The 
results suggest that Zic3 has a dual function as a direct transcriptional activator 
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and repressor in mouse ES cells. This is similar to the core transcription factors 
which have been shown to maintain the ES cell pluripotent state by activating 
genes encoding regulators implicated in ES cell pluripotency while repressing 
genes encoding regulators implicated in lineage specification (Boyer et al., 2005; 
Loh et al., 2006). The repressor role of Zic3 is also not counterintuitive as it can 
be attributed to its structure. In addition to the conserved zinc finger motifs, the 
N-terminal polyhistidine which is found in Drosophila opa, has also been retained 
in the vertebrate Zic3 albeit at a varying length. The polyalanine and polyhistidine 
tracts are believed to function in the repression of transcription (Aruga et al., 
1996).  
 
The genes directly activated by Zic3 are involved in negative regulation of 
differentiation, mesodermal morphogenesis, early nervous system development, 
early skeletal system development and early reproductive system development. 
The activation of genes involved in negative regulation of differentiation 
advocates our lab’s previous findings that Zic3 is required in maintenance of 
pluripotency (Lim et al., 2007). The activation of genes involved in mesodermal 
morphogenesis, skeletal development, nervous system development and 
reproductive development also corroborates previous reports by other groups. 
Ware et al showed that Zic3 is required in early embryogenesis (Ware et al., 
2006b). Purandare et al showed that Zic3 is required in skeletal development and 
nervous system development (Purandare et al., 2002). It was also reported that 
deletion of Zic3 results in reduced fertility (Carrel et al., 2000). Once again, these 
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findings corroborate with the diverse developmental role of Zic3. The genes 
directly repressed by Zic3 are involved in late nervous system development, late 
cardiovascular development and late reproductive system development. Since 
Zic3 regulates pluripotency which encompasses unlimited self-renewing capacity, 
this raises a possibility that during lineage specification, Zic3 promotes the self-
renewal of early progenitors while suppressing terminal differentiation. Some 
examples of Zic3-directly repressed genes in late developmental processes are 
Fst, Fndc3a and Gdj9 which have been implicated in gonad development and 
spermatid differentiation, Fhl2, Adm and Tsc1 in heart morphogenesis, as well as 
Pou3f1, Dst and Efnb1 which have been implicated in neuronal projection and 
neuronal myelination. The repression of late nervous system development may 
first appear contradicting. However, this finding agrees with previous report on 
Zic family members in promoting expansion of neural progenitors and repressing 
neuronal maturation (Aruga et al., 2002a). Together with the embryonic 
expression of Zic3 in the ectoderm and mesoderm, these findings suggest that 
Zic3 activates genes involved in suppression of differentiation in ES cells, but 
also activates early developmental genes to poise them for development, while 
repressing late stage development. 
 
A substantial number of genes that are directly activated by Zic3 are co-bound by 
other ES cell regulators - Nr5a2, Nanog, Oct4, Sox2, Smad1 and Stat3 - as well 
as transcriptional co-activators p300 whereas genes that are repressed by Zic3 
are co-bound by polycomb protein Suz12 (Figure 12). p300 has been shown to 
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be preferentially localised to Oct4-centric module. Studies have shown that 
Oct4/Sox2/Nanog-bound enhancers are physically linked to the promoters of 
active genes via p300 and other mediators (Kagey et al., 2010). Therefore, 
transcription factors in the Oct4-centric modules bind active enhancers and 
recruit p300 which in turn controls the activity of the transcriptional machinery 
(Conaway et al., 2005; Malik and Roeder, 2005; Roeder, 1998; Taatjes, 2010). 
Nanog, Oct4, Sox2, Smad1 and Stat3 are members of the Oct4-centric module 
(Chen et al., 2008). The co-occupancy of Zic3 with p300 and the members of the 
Oct4-centric module suggests that Zic3 may be part of the Oct4-centric module 
that exhibits characteristic ES cell-specific enhancer activity. Further investigation 
of co-occupancy of Zic3 with members of the Myc-centric module, c-Myc, n-Myc 
and Zfx showed that these regulators occupied Zic3-directly activated and 
repressed genes equally (Figure 12). Therefore, they may not mediate Zic3-
driven transcriptional regulation. This advocates that Zic3 is a member of the 
Oct4-centric module. Additionally, Suz12 co-occurred with Zic3 at Zic3-repressed 
genes. Suz12 is an essential factor in the Polycomb Repressive Complex 2.  
Together, this complex represses transcription through methylation of H3K27. 
This suggested that Zic3 may recruit Suz12 to regulate those genes. Altogether, 
the findings show that Zic3-transcriptional activation may be mediated by 
recruitment p300 and other known ES cell regulators, whereas Zic3-


















CHAPTER 3:  
DECONSTRUCTING THE COMBINATORIAL 
INTERACTIONS OF ZIC3 AND KNOWN REGULATORS  






The transcriptional network in ES cells maintains the pluripotent state by 
activating genes necessary for self-renewal while repressing genes involved in 
lineage specification (Boyer et al., 2005; Loh et al., 2006). Genome-wide 
mapping studies of different ES cell regulators have facilitated the identification of 
their binding sites, and thus generated an extensive ES transcriptional network 
that is still expanding. This network is coordinated by the core transcription 
factors, Oct4, Sox2 and Nanog which form an interconnected autoregulatory 
loop, positively regulating their own promoters.  Oct4, Sox2 and Nanog generally 
occupy sites with enhancer activity to promote expression of active genes in ES 
cells. They also occupy genes encoding lineage-specific regulators which are 
repressed in ES cells. However, these sites are not occupied by Oct4, Sox2 and 
Nanog alone. Other transcription factors implicated in maintenance of the ES cell 
pluripotent state also occupy Oct4/Sox2/Nanog-bound loci, forming sites termed 
multiple-transcription factor-binding loci (MTL). Most Oct4/Sox2/Nanog-regulated 
genes are co-occupied by one or more ES cell-specific regulators. Some of these 
known regulators include Stat3, Nr5a2, Esrrb, Tcfcp2l1, Smad1, Eset, Klf4, Zfx, 
Sin3a, c-Myc, n-Myc, E2f1, Ring1B, Rest, Suz12 and Ezh2 (refer to Table 1 for 
functions of these regulators). I have suggested in Chapter 2 that Zic3 may be an 
integral component of the Oct4-centric module. This leads to the next question of 
whether there are combinatorial interactions of Zic3 with specific ES cell 
regulators in the regulation of cell fate specification. In this chapter, I report that 
Zic3 participates in the ES cell gene expression program via combinatorial 
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binding to MTLs with other known ES cell regulators. Zic3 and core ES cell 
regulators co-bind genes involved in pluripotency. In addition, combinatorial 
interactions between specific ES regulators are involved in distinct biological 
pathways - Zic3, Stat3 and E2f1 co-bind genes involved in the haematopoietic 
system; Zic3, Nr5a2 and Esrrb co-bind genes involved in the cardiovascular 
system and kidney development; Zic3 and Tcfcp2l1 co-bind genes involved in 
nervous system and kidney development. Zic3 alone binds genes involved in the 




3.2.1. The binding profile of Zic3 is similar to that of the transcription 
factors in the Oct4-centric module 
To examine how Zic3 integrates into the ES cell regulatory network, I compared 
the genome-wide binding data of Zic3 with that of other known ES cell regulatory 
factors. I included Oct4, Sox2, Nanog, Esrrrb, Zfx, Eset1 which are known 
regulators of pluripotency and self-renewal (Table 1); c-Myc, n-Myc, Klf4 and 
Nr5a2 which have been implicated in reprogramming and maintenance of 
pluripotency (Table 1); Tcfcp2l1 which is preferentially upregulated in mouse ES 
cells but has hitherto not been characterized (Ivanova et al., 2006); and E2f1 
which is a cell-cycle regulator associated with promoters (Bieda et al., 2006). 
Transcriptional coregulators Suz12, Ezh2 and RING1B were also included. 
Suz12, Ezh2 and RING1B are corepressors. Pol2 was included to identify 
promoters. Histone marks H3K4me3 and H3K27me3 were also included to 
identify regions that are activated and repressed, respectively. H3K4me1 and 
H3K4me2 mark promoter and enhancer regions. Hierarchical clustering was 
performed using binding peaks of these factors occurring at H3K4me1 and 
H3K4me2 binding peaks in mouse ES cells. From the clustering results, three 
distinct clusters were observed. The first cluster consists of Oct4, Sox2, Nanog, 
Stat3, Nr5a2, Esrrb, Tcfcp2l1, Smad1 and Tbx3. The second cluster consists of 
Eset, Klf4, Zfx, Sin3A, c-Myc, n-Myc, E2f1, Pol2, H3K4me2 and H3K4me3. The 
third cluster consists of RING1B, REST, Suz12, Ezh2 and H3727me3. 
Interestingly, Zic3 clusters most closely with the core transcription factor trio, 
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Oct4, Sox2 and Nanog, followed by transcription factors Stat3, Nr5a2, Esrrb, 
Tcfcp2l1, Smad1 and Tbx3 (Figure 13). This cluster resembles the previously 
reported Oct4-centric module (Chen et al., 2008). The Myc-centric module 
reported by Chen et al consisted of c-Myc, n-Myc and E2f1. This cluster is 
representative of promoter regions. In my hierarchical clustering, Zic3 binding 
profile was not biased towards promoters that were bound by E2f1 or the Myc 
family. This suggested that Zic3 is an integral component of the core ES cell 
circuitry and works closely with Oct4, Sox2 and Nanog. Together with the 
members of the Oct4-centric module, Zic3 co-occupies MTLs which possess 
characteristic ES cell enhancer activity. Two examples of such MTLs that were 
co-occupied by Zic3 and the members of the Oct4-centric module are the 
enhancer regions of Oct4 (Figure 14A) and Nanog (Figure 14B). These loci were 
not repressed by Suz12 but were marked by H3K27ac which is an indicator of 
active enhancers (Figure 13). Therefore, such MTLs are transcriptionally 




Figure 13. Comparison of genome-wide binding data of Zic3 to that of other factors important in 
embryonic stem cells. Hierarchial clustering was done using ChIP-seq binding data of these 
transcription factors occurring at H3K4me1 peaks in mouse ES cells.  
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Figure 14. Multiple transcription factor-binding loci on Oct4 and Nanog. (A) Binding peaks of 
E2f1, H3K27ac, Esrrb, Klf4, Nanog, Nr5a2, Oct4, Smad1, Sox2, Stat3, Suz12, Tcfcp2l1 and 
Zic3 on the Oct4/Pou5f1 gene loci. (B) Binding peaks of E2f1, H3K27ac, Esrrb, Klf4, Nanog, 




3.2.2. Zic3 co-occupies genomic loci with specific ES cell regulators in a 
role-dependent fashion  
After identifying the co-occurrence of Zic3 at the MTLs, I next asked whether 
these MTLs determine specific biological functions in a fashion that is dependent 
on the combinatorial interaction of specific transcription factors. Therefore, I 
interrogated Zic3-binding data by examining the co-occurrence of Zic3 with the 
ES cell regulators of the Oct4-centric module that clustered closely with Zic3 - 
Oct4, Sox2, Nanog, Stat3, Nr5a2, Esrrb, Tcfcp2l1, Smad1 and Tbx3 (Figure 13). 
Clustering was performed using ChIP-seq binding signals of these factors that 
occurred at the top 10,000 Zic3 binding peaks. Members of the Myc-centric 
cluster, c-Myc and Eset, which did not cluster closely with Zic3 (Figure 13) were 
included to denote promoter regions. H3K4me3 and H3K27me3 were also 
included to identify active and repressed regions, respectively. Interestingly, 
specific combinations of transcription factors appear to colocalize on specific 
genomic loci. With this information, I categorised the ES cell regulators into 
distinct classes (Figure 15 and Table 2). Zic3 occupancy was found at bivalent 
promoters which are denoted by H3K4me3 and H3K27me3 occupancy (Class I), 
and active promoters which are denoted by H3K4me3, Pol2 and c-Myc 
occupancy (Class VI). Class II was occupied by Zic3 with Stat3 and E2f1. Class 
III regions were occupied by Zic3 with Oct4, Sox2, Nanog, Smad1, Nr5a2 and 
Tbx3. Class IV regions were occupied by Zic3 with Nr5a2 and Esrrb. Class V 
regions were occupied by Zic3 and Tcfcp2l1. Class VII regions were only bound 
by Zic3. Interestingly, these Class VII regions were enriched with H3K27me3 
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marks suggesting that these might be enhancers or promoters bound by Zic3 
poised for activation (Figure 15, Table 2). 
 
Next, I asked whether these classes indicated preferential biological processes. 
Genes occurring within 20kb of regions in Class II, III, IV, V and VII were 
submitted to GREAT (http://great.stanford.edu/) for Gene Onthology (GO) 
analysis. Interestingly, Class II was enriched for hematopoietic system 
development (Figure 16A, Table 2), Class III was enriched for early 
embryogenesis specifically axis specification (Figure 16B, Table 2), Class IV was 
enriched for cardiovascular and kidney development (Figure 16C, Table 2), Class 
V was enriched for nervous system and kidney development (Figure 16D, Table 
2), and finally, Class VII was enriched for nervous and skeletal system 
development (Figure 16E, Table 2). Abnormalities in most of these development 
systems have been reported in Zic3-mutants. Together, these data suggested 
that Zic3 is an important regulator in these processes, primarily pluripotency, 











Figure 15. Identification of binding signals of embryonic stem cell regulators occurring at 
Zic3-bound regions. Clustering was done using ChIP-seq data of the ES cell regulators 
ocurring within top 10,000 Zic3-binding peaks.  
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CLASS II A 
Biological Process Mouse Phenotype 
CLASS III B 
Biological Process Mouse Phenotype 
CLASS IV C 
Biological Process Mouse Phenotype 
CLASS V D 
Biological Process Mouse Phenotype 
CLASS VII E 




Class Co-occurring TFs/ Histone marks Roles 
II Stat3 and E2f1 Hematopoietic system development 
 
III Oct4, Sox2, Nanog, Smad1, Tbx3 Pluripotency and early development 
 
IV Nr5a2 and Esrrb Cardiovascular and kidney development 
 
V Tcpcfcl1 Nervous system and kidney development 
 
VII H3K27me3 Nervous and skeletal system development 
Figure 16. Gene ontology analysis of Class II, III, IV, V and VII Zic3-bound regions. (A) Class II 
was enriched for hematopoietic system. (B) Class III was enriched for early embryo development 
specifically axis specification. (C) Class IV was enriched for cardiovascular and kidney 
development. (D) Class V was enriched for nervous and kidney development. (E) Class VII was 
enriched for nervous and skeletal system development. 
 
Table 2. Summary of the Gene Ontology analysis of Class II, III, IV, V and VII. 
 56 
3.3. Discussion 
ES cells have a program that permits self-renewal while simultaneously poises 
for differentiation upon reception of the right developmental cues. This program is 
maintained by a transcriptional network that is orchestrated by a myriad of 
transcription factors. Chen et al performed genome-wide mapping of these 
transcription factors and revealed an extensive co-regulatory mechanism in ES 
cells as evidenced by the combinatorial binding of gene loci by multiple 
transcription factors (Chen et al., 2008). The authors also reported a total of 
3,583 MTLs that are bound by four or more transcription factors, and gene 
expression at these MTLs is proportional to the number of transcription factors 
bound. Promoters that are bound by multiple factors are preferentially expressed 
in ES cells whereas singly bound promoters are inactive in ES cells but activated 
upon differentiation. This combinatorial binding discovered by Chen et al as well 
as Kim et al can be grouped into two distinct clusters (Chen et al., 2008; Kim et 
al., 2008). They are the Oct4-centric module which consists of Oct4, Sox2, 
Nanog, Stat3, Smad1, Klf4, Esrrb, Dax1, Tcf3, Zfp281 and Tcfcp2l1, and the 
Myc-centric module which consists of c-Myc, n-Myc, E2f1, Zfx, Ronin, Rex1 and 
CTCF. In this report, I compared the Zic3 binding profile to those of the 
aforementioned transcription factors to better understand how Zic3 integrates 
into the ES cell transcriptional network. I also included more ES cell-specific 
regulators for a more extensive analysis. Results show that these factors can be 
grouped into three instead two major clusters – the expanded Oct4-centric 
module, the expanded Myc-centric module and the repressor-centric module 
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(Figure 13). This newly expanded Oct4-centric cluster consists of Zic3, Oct4, 
Sox2, Nanog, Stat3, Nr5a2, Esrrb, Tcfcp2l1, Smad1 and Tbx3, and is similar to 
the Oct4-centric module reported by Chen et al. Some of these MTLs are found 
to be enriched with H3K27ac (Figure 14). H3K27ac indicates an active enhancer. 
Therefore the presence of H3K27ac advocates that these Oct4-centric modules 
possess enhancer activity. The co-occurrence of p300 with Zic3 and some of 
these ES cell regulators reported in Chapter 2 (Figure 12) also advocates that 
these Oct4-centric modules possess enhancer activity. These enhancer activities 
may promote transcriptional activation of genes such as Oct4 and Nanog (Figure 
14) required for ES cell stemness. Within the expanded Oct4-centric module, 
Zic3 binding profile is most similar to that of Oct4, Sox2 and Nanog compared to 
the other ES cell-specific transcription factors, suggesting that Zic3 has the most 
similar ES cell-specific transcriptional activity to the core ES cell transcription 
factors – Oct4, Sox2 and Nanog, and may work closely with them to control 
pluripotency and lineage specification. 
 
The newly expanded Myc-centric module consists of Eset1, Klf4, Zfx, Sin3a, c-
Myc, n-Myc, E2f1, Pol H3K4me2 and H3K4me3. This cluster is similar to the 
Myc-centric module reported by Chen et al. The co-occurrence of Pol2 in this 
group further advocates that these factors bind promoter regions. The presence 
of H3K4me3 also suggests that these regions are transcriptionally active. In 
addition, I discovered a third cluster that consists of RING1B, REST, Suz12, 
Ezh2 and H3K27me3. These factors are all either transcriptional repressors or 
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chromatin remodelers that repress transcriptions (Table 1). The presence of 
H3K27me3 also suggests that these regions are transcriptionally inactive. This 
cluster may represent genes that are actively repressed in ES cells and further 
investigation is required. Overall, these results advocate that Zic3 co-occurs at 
Oct4-centric modules and thus is an integral component of the core ES cell 
regulatory network.   
 
A closer look at the co-occupancies of Zic3 with transcription factors in the Oct4-
centric module revealed an intriguing pattern of multiple transcription factor 
binding (Figure 15,16). Specific classes of transcription factors were observed 
and each individual class when subjected to GO analysis, exhibits specific 
biological pathways. Genes that are co-occupied by Zic3 and Oct4-centric factors 
(Oct4, Sox2, Nanog, Smad1 and Tbx3) are involved primarily in pluripotency and 
early embryonic development. This result is not surprising and corroborates 
previous findings that these transcription factors are known to regulate 
transcription in ES cells. This again advocates that Zic3 plays an integral role in 
the ES cell regulatory network. Genes that are co-occupied by Zic3, Stat3 and 
E2f1 are involved in haematopoietic development. Stat3 and E2f1 have been 
shown to be involved in the development of the haematopoietic system (Li et al., 
2003; Nakao et al., 2002; Takeda et al., 1998; Takeda et al., 1997). However, 
Zic3 has hitherto not been shown to be involved in haematopoietic development, 
though haematopoietic system is developed from the mesoderm and Zic3 is 
expressed in the embryonic mesoderm (Nagai et al., 1997; Ware et al., 2006b). 
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Since, GO analysis did not enrich for the haematopoietic system in Zic3 directly-
regulated genes, Zic3 may not be directly regulating the haematopoietic system 
but more so in the early specification in the mesoderm. Genes that are co-
occupied by Zic3, Nr5a2 and Esrrb are involved in cardiovascular development 
and kidney development. Neither Nr5a2 nor Esrrb have been associated with 
cardiovascular and kidney development. Nr5a2 has been implicated in 
development of cells derived from the endodermal lineage and the germ cells 
(Fayard et al., 2004). Zic3 has been shown to be involved in cardiovascular 
development but not in kidney development (Zhu et al., 2007). Again, these 
tissues are developed from the mesoderm. Development usually involves a 
series of transcription factors, and deletion of one gene may not be sufficient to 
exhibit a defective phenotype due to functional redundancies. Hence, Nr5a2 and 
Esrrb may work together with Zic3 to regulate development of these systems. 
Genes that are co-occupied by Zic3 and Tcfcp2l1 are involved in nervous system 
and kidney development. Tcfcp2l1 has been implicated in kidney development 
(Yamaguchi et al., 2006). Genes that are co-occupied by Zic3 alone are involved 
in skeletal and nervous system development. Zic3 is known to be involved in 
skeletal and nervous system development (Nagai et al., 1997; Purandare et al., 
2002). Notably, these Zic3-only bound loci are also marked by H3K27me3. This 
is not surprising as these genes are not expressed in mouse ES cells and the 
presence of H3K27me3 renders transcription inactive. This suggests that Zic3 
may be binding to these loci and poising them for transcriptional activation. 
Together, the findings suggest that the concerted interplay of Zic3 with specific 
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transcription factors orchestrates pluripotency and lineage specification, 



















CHAPTER 4:  







Takahashi et al reported that somatic cells can be reprogrammed into induced 
pluripotent stem cells via forced expression of Oct4, Sox2, Klf4 and c-Myc 
(Takahashi and Yamanaka, 2006). During reprogramming, the forced expression 
of these factors reactivates endogenous expression of the core transcription 
factor trio, Oct4, Sox2 and Nanog. This results in an initiation of a positive-
feedback loop which re-establishes the ES cell gene expression program 
(Jaenisch and Young, 2008). I have shown earlier in the previous chapter that 
the genome-wide occupancy of Zic3, out of the numerous known ES cell 
regulators, is the most similar to that of Oct4, Sox2 and Nanog. In addition, Zic3 
is also part of the Oct4-centric module that runs the ES cell program which 
maintains pluripotency and early embryonic development. This therefore places 
Zic3 within an important loop associated with key pluripotent factors, suggesting 
that Zic3 may enhance pluripotency. In this chapter, I show that Zic3 enhances 
reprogramming. On further analysis of how Zic3 participates in the maintenance 




4.2.1. Zic3 enhances reprogramming 
To test whether Zic3 is able to enhance reprogramming, I subjected mouse 
embryonic fibroblasts (MEFs) engineered with a GFP reporter gene downstream 
of the endogenous Oct4 promoter (Oct4-GFP) to a reprogramming assay. Oct4-
GFP is normally silenced in somatic cells but is reactivated in induced pluripotent 
cells during reprogramming. Using a pMX-Zic3 construct that was previously 
generated in the lab (Lim, 2008), I overexpressed Zic3 together with the four 
factors, Oct4, Sox2, Klf4 and c-Myc, in Oct4-GFP MEFs. After two weeks of 
overexpression, I quantitated the number of Oct4-GFP-postitive colonies. 
Compared to the control experiment where only Oct4, Sox2, Klf4 and c-Myc were 
overexpressed (Figure 17A,C), I observed that overexpression of Zic3, Oct4, 
Sox2, Klf4 and c-Myc established twice the number of Oct4-GFP-postive 




Figure 17. Zic3 enhances reprogramming. (A) In the control experiment, Oct4-GFP MEFs 
were transduced with Oct4, Sox2, Klf4 and c-Myc. (B) Oct4-GFP MEFs were transduced 
with Oct4, Sox2, Klf4, c-Myc and Zic3. (C) Oct4-GFP colonies were quantitated two 
weeks post-transduction.  Scale bar represents 200 m. Each experiment was performed 
with three biological replicates and three technical replicates. Error bars are 
representative of standard error.  
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4.2.2. Zic3 binds to the putative consensus motif with high affinity and 
specificity, and directly activates Nanog expression. 
In the previous two chapters, I have shown that Zic3 is capable of directly 
activating and repressing transcription. However, Zic family members were 
previously reported to bind the Gli family’s binding sequence 5’-GGGTGGTC-3’ 
in vitro, and this occurs at a much lower affinity than that of Gli proteins 
(Mizugishi et al., 2001). This suggested that Zic family members function as 
transcriptional coregulators of Gli rather than direct transcriptional regulators. To 
prove that Zic3 is indeed a direct transcriptional activator, I proceeded to identify 
the Zic3 binding motif. The top 1000 Zic3 binding peaks derived from ChIP-seq 
were subjected to MEME analysis which generated a putative Zic3 consensus 
binding motif 5’-CC[T/C/A]GG[T/A]C[T/G/A]-3’ (Figure 18) that is slightly different 
from the Gli binding motif. Lim et al previously reported that depletion of Zic3 
results in a downregulation of Nanog transcript (Lim et al., 2007). Therefore, I 
asked whether Zic3 is a direct regulator of Nanog. Interestingly, the putative 
consensus binding motif was identified in the Nanog promoter region between     
-347 to -341 from the translation start codon (Figure 19A). To do that, I 
investigated whether Zic3 is able to directly bind to the putative Zic3 consensus 
binding motif and activate transcription.  
 
I expressed the DNA binding domain (DBD) of Zic3 tagged with Histidine and 
Maltose binding protein (HisMBP) at the N-terminus (mZic3-DBD-HisMBP), and 
affinity purified the His-tagged protein. I first examined the DNA binding affinity of 
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mZic3-DBD-HisMBP by electrophoretic mobility gel shift assay (EMSA) with DNA 
probes composed of the putative consensus Zic3 binding motif. I synthesized five 
Cy5-labelled 16-mer DNA probes corresponding to the consensus Zic3 binding 
motif found in the following gene promoters: Nanog, Pou5f1, Klf6, Agtrap and 
Mbtps2 (Table 3; Figure 19A,D,G,J,M). To determine the binding affinity of the 
mZic3-DBD-HisMBP, I incubated all five probes with 0-500 nM (2-fold serial 
dilutions) of mZic3-DBD-HisMBP. mZic3-DBD-HisMBP bound and shifted all five 
probes, and as expected, more probes were shifted with increasing concentration 
of protein (Figure 19B,E,H,K,N). An average Kd of approximately 3 nM was 
obtained (Figure 19C,F,I,L,O). To ensure that the DBD was bound to DNA and 
not the HisMBP tag, I incubated each of the five probes with 500 nM HisMBP. As 
expected, no shift of the probes was observed, thus confirming that the HisMBP 
does not bind DNA (Figure 19B,E,H,K,N lane 15). 
 
Next, I examined whether mZic3-DBD-HisMBP binds specifically to the 
consensus binding motif. I synthesized unlabelled 16-mer competitors for each of 
the five probes (Table 3; Figure 20A,D,G,J,M), and allowed 0-500 nM of 
competitor to compete with the corresponding probe for 3 nM of mZic3-DBD-
HisMBP. Indeed, increasing concentrations of the competitor showed competition 
with the probe for binding to mZic3-DBD-HisMBP (Figure 20B,E,H,K,N). As a 
negative control, I randomly scrambled the Zic3 binding motif on all five 
competitors (Table 3; Figure 20A,D,G,J,M), and allowed them to compete with 
the corresponding probe for binding to mZic3-DBD-HisMBP. As expected, the 
scrambled competitors did not show competition with their corresponding probe 
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for binding to mZic3-DBD-HisMBP (Figure 20C,F,I,L,O). Hence, this indicated 
that mZic3-DBD-HisMBP binds specifically to the consensus binding motif, and 
therefore could directly bind the Nanog promoter.  
 
To examine whether Zic3 directly regulates Nanog expression, I cloned the 
Nanog promoter, which comprises the Zic3 binding motif, upstream of a 
luciferase reporter gene (Figure 21A). ES cells were cotransfected with the 
Nanog-luciferase construct and a previously generated Zic3 shRNA (Lim et al., 
2007). Depletion of Zic3 by shRNA resulted in approximately 50% reduction in 
Nanog-luciferase activity when compared to the control experiment in which 
mouse ES cells were cotransfected with the Nanog-luciferase construct with an 
empty shRNA vector (Figure 21B). Overexpression of Zic3 resulted in a three-
fold enhancement of Nanog-Luciferase activity when compared to the control 
experiment in which mouse ES cells were cotransfected with the Nanog-
luciferase construct and a haemagglutinin (HA) overexpression construct (Figure 
21C). This indicated that Zic3 directly binds and regulates the Nanog promoter. 
Overexpression of Zic3 also exhibits an upregulation of Nanog expression in 









Figure 18. Zic3 consensus binding motif in mouse embryonic stem cells generated from 










EMSA oligos Sequence(s) 
Cy5-labelled DNA probe (16-mer) 
Nanog  F 5' Cy5 ggaccctgcaggtggg 3' 
 R 5' Cy5 cccacctgcagggtcc 3' 
Pou5f1  F 5' Cy5 tgccccctctggggac 5' 
 R 5' Cy5 gtccccagagggggca 3' 
Klf6  F 5' Cy5 gaaacctgcgggcacg 3' 
 R 5' Cy5 cgtgcccgcaggtttc 3' 
Agtrap  F 5' Cy5 tcccctgctgagcctt 3' 
 R 5' Cy5 aaggctcagcagggga 3' 
Mbtps2  F 5' Cy5 gcctcctgctggctgc 3' 
 R 5' Cy5 gcagccagcaggaggc 3' 
WT unlabelled competitor (16-mer) 
Nanog  F 5' ggaccctgcaggtggg 3' 
 R 5' cccacctgcagggtcc 3' 
Pou5f1  F 5' tgccccctctggggac 5' 
 R 5' gtccccagagggggca 3' 
Klf6  F 5' gaaacctgcgggcacg 3' 
 R 5' cgtgcccgcaggtttc 3' 
Agtrap  F 5' tcccctgctgagcctt 3' 
 R 5' aaggctcagcagggga 3' 
Mbtps2  F 5' gcctcctgctggctgc 3' 
 R 5' gcagccagcaggaggc 3' 
Mutated (scrambled) unlabelled competitor (16-mer) 
Nanog  F 5' ggacggccgtcatggg 3' 
 R 5' cccatgacggccgtcc 3' 
Pou5f1  F 5' tgcggcccgtctcgac 3' 
 R 5' gtcgagacgggccgca 3' 
Klf6  F 5' gaaaggccgtcgcacg 3' 
 R 5' cgtgcgacggcctttc 3' 
Agtrap  F 5' tccgagccccgtctctt 3' 
 R 5' aagagacggggctcgga 3'  
Mbtps2 F 5' ggctggccgtctctgc 3' 
 R 5' gcagagacggccagcc 3' 
Table legend  
Red - Zic3 binding motif  
Underlined - scrambled Zic3 binding motif 
 











































Lanes 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Zic3-DBD-HisMBP (nM) 0 0.12 0.24 0.49 0.98 1.95 3.91 7.81 15.6 31.3 63 125 250 500 - 
Probe (1 nM) + + + + + + + + + + + + + + + 












Figure 19. Binding affinity of Zic3 to the consensus binding motif. (A,D,G,J,M) Map of Zic3 consensus 
binding motif on promoter of Nanog (A), Pou5f1 (D), Klf6 (G), Agtrap (J) and Mbtps2 (M) from the translation 
start codon (ATG). (B,E,H,K,N) EMSA performed using 0-500 nM (2-fold serial dilution) of Zic3 and 1 nM 
Cy5-labelled DNA probes composed of Zic3 consensus binding motif on Nanog (B), Pou5f1 (E), Klf6 (H), 
Agtrap (K) and Mbtps2 (N). (C,F,I,L,O) Dissociation constant calculated based on the fraction of probes 
Nanog (C), Pou5f1 (F), Klf6 (I), Agtrap (L) and Mbtps2 (O), bound to protein. (P) Concentration of probes and 































Lanes 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Competitor (nM) 0 0.06 0.12 0.24 0.49 0.98 1.95 3.91 7.81 15.6 31.3 63 125 250 
Probe (1 nM) + + + + + + + + + + + + + + 
Zic3-DBD-HisMBP (3 nM) + + + + + + + + + + + + + + 
Figure 20. Binding specificity of Zic3 to the consensus binding motif. (A,D,G,J,M) Wild-type (WT) and 
mutated (mut) sequences of competitors used in the competitive gel shift assay against the Zic3 
consensus binding motif on Nanog (A), Pou5f1 (D), Klf6 (G), Agtrap (J) and Mbtps2 (M) for binding to Zic3. 
(B,E,H,K,N) Competitive gel shift assay using WT competitors. 0-500 nM (2-fold serial dilution) of 
unlabelled WT competitors were allowed to compete for binding to 3 nM Zic3 with 1 nM Cy5-labelled DNA 
probes composed of Zic3 consensus binding motif on Nanog (B), Pou5f1 (E), Klf6 (H), Agtrap (K) and 
Mbtps2 (N). (C,F,I,L,O) Competitive gel shift assay using mutant competitors. 0-500 nM (2-fold serial 
dilution) unlabelled mutant competitors were allowed to compete for binding to 3nM Zic3 with 1 nM Cy5-
labelled DNA probes composed of Zic3 consensus binding motif on Nanog (C), Pou5f1 (F), Klf6 (I), Agtrap 
(L) and Mbtps2 (O). (P) Concentration of competitors, probes and proteins used in each of the competitive 
gel shift assay. 
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Figure 21. Zic3 functionally activates the Nanog promoter. (A) Schematic of Nanog promoter 
consisting of the Zic3 binding motif, cloned upstream of the luciferase reporter gene. (B) Mouse ES 
cells cotransfected with Zic3 shRNA and Nanog-luciferase construct. In the control experiment, 
empty vector. (C) Mouse ES cells cotransfected with Zic3-overexpression and Nanog-luciferase 
construct. Each experiment was performed with three biological replicates and three technical 





































C P<0.05 P<0.05 
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4.2.3. Zic3 and Sox2 bind additively to the Nanog promoter and other 
common target binding sites.  
Coincidentally, binding motifs of Oct4, Sox2, Esrrb and n-Myc occur adjacent to 
the identified Zic3 binding motif on the Nanog promoter (Figure 22). Therefore, I 
investigated whether Zic3 binding co-occurs with other transcription factors in 
proximity. We searched for binding motifs of Oct4, Sox2, Esrrb, and n-Myc in the 
top 1,000 Zic3 peaks via TransFac (Figure 23A-D). Strikingly, the Sox2 motif 
consistently occurs adjacent to the Zic3 peak (Figure 23D-F). Hence, I 
hypothesized that Zic3 and Sox2 co-bind and co-regulate common target genes 
in ES cells. To test the hypothesis, I synthesized five Cy5-labelled 39-mer DNA 
probes that correspond to Zic3 and Sox2 binding sites occurring in proximity to 
the following gene promoters: Nanog, Pou5f1, Klf6, Agtrap and Mbtps2 (Table 4, 
Figure 24). These targets were derived from the chromatin immunoprecipitation 
of Zic3 in mouse ES cells, and selected based on the presence of Zic3 and Sox2 
consensus binding motifs. I first examined the independent binding of Zic3 and 
Sox2 to the probe. Here, I used the mZic3-DBD-HisMBP and Sox2 DBD protein 
(mSox2-HMG)(a kind gift from Jauch et al (Jauch et al., 2011)) for the gel shift 
assays. Both Zic3 and Sox2 bind to all five probes forming a binary Zic3-DNA 
(Figure 25, lane 1-6) or Sox2-DNA complex (Figure 25, lane 13-18), respectively. 
From these results, it is evident that Zic3 and Sox2 bind to DNA independently. I 
then investigated whether Zic3 and Sox2 co-bind DNA. I incubated increasing 
concentrations of Zic3 with each of the five probes in the presence of Sox2. A 
ternary Sox2-Zic3-DNA complex was observed in addition to the binary Zic3-
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DNA complex (Figure 25, lane 7-12). In the reciprocal experiment where 
increasing concentrations of Sox2 were incubated with each of the five probes in 
the presence of Zic3, a ternary Zic3-Sox2-DNA complex was also observed in 
addition to the binary Sox2-DNA complex. This indicated that Zic3 and Sox2 co-




Figure 22. Schematic of Oct4, Sox2, Esrrb, Zic3 and n-Myc binding sites on the Nanog promoter. 
Oct4/Sox2 Esrrb Zic3 n-Myc 
Nanog 
 75 
Figure 23.  Distances between binding motifs of Zic3 and other transcription factors occurring 
near Zic3 peaks: Histogram of distance between (A) Zic3 and Oct4, (B) Zic3 and Sox2, (C) Zic3 
and Esrrb, and (D) Zic3 and n-Myc. (E) Zoomed-in image of distance between Zic3 and Sox2. (F) 
The combined PWM corresponding at the most significant distance between Zic3 (sequence here 
is complimentary to the consensus motif) and Sox2 motifs occurring at Zic3 peaks. 
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EMSA oligos Sequence(s) 
Cy5-labelled DNA probe (39-mer) 
Nanog  F 5' Cy5 tgcattacaatgtccatggtggaccctgcaggtgggatt 3' 
 R 5' Cy5 aatcccacctgcagggtccaccatggacattgtaatgca 3' 
Pou5f1  F 5' Cy5 agagctgccccctctggggaccaggattgtccagccaag 3' 
 R 5' Cy5 cttggctggacaatcctggtccccagagggggcagctct 3' 
Klf6  F 5' Cy5 tcttattgtcccatcgccacagggaaacctgcgggcacg 3' 
 R 5' Cy5 cgtgcccgcaggtttccctgtggcgatgggacaataaga 3' 
Agtrap  F 5' Cy5 tcaggacaattaacaggaagtctcccctgctgagccttc 3' 
 R 5' Cy5 gaaggctcagcaggggagacttcctgttaattgtcctga 3' 
Mbtps2  F 5' Cy5 gtcataacaaagcactgaattgcctcctgctggctgctg 3' 









Figure 24. Schematic of Zic3 and Sox2 binding 
motifs on gene promoters of target genes: Nanog 
(A), Pou5f1 (B), Klf6 (C), Agtrap (D), and Mbtps (E) 
from the translation start codon (ATG).   
 
Table 4. Probes and competitors used to assay for co-binding of Zic3 and Sox2 to DNA. 
Table legend 
Red - Zic3 binding motif 











































Figure 25. Zic3 and Sox2 bind additively to common target gene promoters. Zic3 and Sox2 binding 
sites that occur in proximity on gene promoters of (A) Nanog, (B) Pou5f1, (C) Klf6, (D) Agtrap, and (E) 
Mbtps, were incubated with 0-12.5 nM (2-fold serial dilution) Zic3 (lanes 1-6) and Sox2 (lanes 13-18) 
independently. 0-12.5 nM Zic3 was incubated with probe in the presence of 2 nM Sox2 (lanes 7-12). 0-
12.5 nM Sox2 was incubated with probe in the presence of 2 nM Zic3 (lanes 19-24). 
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4.2.4. Zic3 and Sox2 co-regulate Nanog expression in ES cells. 
Having established the interaction of Zic3 and Sox2 at their common target 
promoters, I sought to understand the regulatory role of these factors in the 
transcription of their target genes. I cloned a 428bp fragment of the Nanog 
promoter, which comprises the Zic3 and Sox2 binding motif, upstream of a 
luciferase reporter gene (Figure 26A). ES cells were cotransfected with the 
Nanog-luciferase construct with either Zic3 shRNA or Sox2 shRNA vector that 
were previously generated and validated in our lab (Lim, 2008). Depletion of Zic3 
by shRNA resulted in approximately 50% reduction in Nanog-luciferase activity 
when compared to the control experiment in which mouse ES cells were 
cotransfected with the Nanog-luciferase construct with an empty shRNA vector 
(Figure 26B). Depletion of Sox2 by shRNA resulted in approximately 80% 
reduction in Nanog-Luciferase activity when compared to the control experiment 
in which mouse ES cells were cotransfected with the Nanog-luciferase construct 
with an empty shRNA vector (Figure 26B). Overexpression of either Zic3 or Sox2 
resulted in a respective 3-fold or 4-fold enhancement of Nanog-Luciferase activity 
when compared to the control experiment in which mouse ES cells were 
cotransfected with the Nanog-luciferase construct and a HA overexpression 
construct (Figure 26C). This indicated that both Zic3 and Sox2 indeed co-bind 
target genes and directly regulate their expression. In addition, the result also 
indicated that both Zic3 and Sox2 are required for regulating target gene 
expression, and depletion of either Zic3 or Sox2 affects target gene expression.  
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I next asked whether overexpression of Zic3 would rescue Nanog-luciferase 
activity upon knockdown of Sox2, and conversely, would overexpression of Sox2 
rescue Nanog-luciferase activity upon knockdown of Zic3. I cotransfected mouse 
ES cells with the Nanog-luciferase construct, Sox2 shRNA and Zic3 
overexpression construct. As a control, I overexpressed HA in place of Zic3. 
Interestingly, when Sox2 was knocked down with shRNA, Nanog-luciferase 
activity was rescued by Zic3 overexpression (Figure 26D). In the reciprocal 
experiment, I cotransfected mouse ES cells with the Nanog-luciferase construct, 
Zic3 shRNA and Sox2 overexpression construct. Similarly, when Zic3 was 
depleted, Nanog-luciferase activity was rescued by overexpression of Sox2 
(Figure 26D). This suggested possible redundancy in their transcriptional 


































Figure 26. Zic3 and Sox2 directly activate Nanog expression in embryonic stem cells. (A) 
Schematic of luciferase reporter construct with Zic3 and Sox2 binding site in the Nanog promoter 
upstream of the luciferase gene. (B) ES cells cotransfected with the Nanog-luciferase reporter 
and either Zic3 or Sox2 shRNA resulted in a significant drop of Nanog-Luciferase activity 
compared to ES cells cotransfected with the Nanog-luciferase reporter and an empty shRNA 
vector. Control luciferase reporter did not show significant Luciferase activity. (C) ES cells 
cotransfected with Nanog-luciferase reporter and either Zic3 or Sox2 overexpression (O/E) 
construct in ES cells resulted in an enhanced Nanog-Luciferase activity compared to ESCs 
cotransfected with the Nanog-luciferase reporter and a HA overexpression construct. (D) Zic3 or 
Sox2 overexpression rescues Nanog-luciferase activity when Sox2 and Zic3 are knockdown with 
shRNA, respectively. ES cells cotransfected with Nanog-luciferase reporter, Sox2 shRNA and 
Zic3 overexpression construct enhanced Nanog-luciferase activity compared to ES cells 
cotransfected with the Nanog-luciferase reporter, Sox2 shRNA and HA overexpression construct. 
ES cells cotransfected with Nanog-luciferase reporter, Zic3 shRNA and Sox2 overexpression 
construct enhanced Nanog-Luciferase activity compared to ES cells cotransfected with the 
Nanog-luciferase reporter, Zic3 shRNA and HA overexpression construct. Each experiment was 
performed with three biological replicates and three technical replicates. Error bars are 
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4.2.5. Zic3 is necessary but not sufficient to maintain pluripotency. 
Mouse ES cells require LIF to maintain pluripotency (Smith et al., 1988; Williams 
et al., 1988). It was previously reported that overexpression of Nanog abrogates 
the requirement for LIF (Chambers et al., 2003). Since Zic3 directly activates 
Nanog expression, and was previously shown to be required in maintaining 
pluripotency, I next asked whether overexpression of Zic3 is able to maintain 
pluripotency in the absence of LIF. Using a previously generated doxycyline-
inducible-Zic3 overexpression ES cell line (Lim et al., 2010), I overexpressed 
Zic3 and withdrew LIF for a week. Intriguingly, Zic3 overexpression was unable 
to maintain pluripotency of ES cells (Figure 27B,D). Instead, Zic3 overexpression 
upon withdrawal of LIF resulted in a decrease in transcript levels of pluripotent 
markers Oct4, Sox2 and Nr5a2 (Figure 28). More strikingly, cells exhibited 
accelerated differentiation upon Zic3 overexpression in the absence of LIF as 
compared to the control which still contained proliferating ES cell colonies (Figure 
27A,C). Our lab previously reported that depletion of Zic3 resulted in 
spontaneous differentiation into the endodermal lineage. Corroborating our 
previous findings, overexpression of Zic3 upon withdrawal of LIF resulted in the 
downregulation of transcripts of endodermal markers Sox17, Pdgfra, Foxa2 and 
Gata4 (Figure 29). A subsequent microarray was performed on these cells at the 
fourth day of LIF withdrawal in the lab and the results also showed a significant 
over-representation of genes involved in ectodermal and mesoderm 




Figure 27. Zic3 overexpression in the absence of LIF accelerates differentiation of 
embryonic stem cells. LIF withdrawal assay using inducible-Zic3 ES cell clone #1 and #2. 
Inducible-Zic3 #1 was subjected to LIF withdrawal assay in the (A) absence of Zic3 
overexpression, and (B) with induced Zic3 overexpression. Inducible-Zic3 #2 was 
subjected to LIF withdrawal assay in the (C) absence of Zic3 overexpression, and (D) 
with induced Zic3 overexpression. Arrow illustrates examples of proliferating ES cell 
colonies. Scale bar represents 500 µm. 






























Figure 28. Zic3 overexpression drives differentiation in the absence of LIF. Transcript levels 
of pluripotent markers (A) Zic3, (B) Oct4, (C) Sox2 and (D) Nr5a2 of control cells (no 
overexpression) treated with LIF, control cells subjected to 7 days of LIF withdrawal, Zic3-
overexpressing cells treated with LIF, and Zic3-overexpressing cells subjected to 7 days of 
LIF withdrawal. Markers were assayed by qPCR at day 4 and 7 of differentiation. Each 
experiment was performed with three biological replicates and three technical replicates. 




Figure 29. Zic3 overexpression suppresses the endodermal lineage. Transcript levels of 
endodermal markers Sox17, Pdgfa, Foxa2 and Gata4 of control cells (no overexpression) 
treated with LIF, control cells subjected to 7 days of LIF withdrawal, Zic3-overexpressing 
cells treated with LIF, and Zic3-overexpressing cells subjected to 7 days of LIF withdrawal. 
Each experiment was performed with three biological replicates and three technical 
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4.3. Discussion 
The addition of Zic3 into the reprogramming cocktail has enhanced 
reprogramming (Figure 17). Coincidentally, it was shown that Zic3 is upregulated 
in reprogrammed cells (Mikkelsen et al., 2008). This re-establishment of Zic3 
expression upon ectopic expression of the reprogramming cocktail is similar to 
that of the core transcription factors Oct4, Sox2 and Nanog, Therefore, the ability 
of Zic3 to enhance reprogramming may be accounted for the re-establishment of 
a positive-feedback autoregulation in a fashion similar to Oct4, Sox2 and Nanog. 
The concerted interplay of Zic3, Oct4, Sox2 and Nanog then re-establishes the 
ES cell program and thus enhances reprogramming. Since Zic3 works closely 
with the core transcription factors, I next focused on the direct effect of Zic3 on 
the core transcription factors to further our understanding on how Zic3 
participates in the pluripotency program.  
 
It was previously shown that depletion of Zic3 results in significant 
downregulation of Nanog transcript but only modest downregulation of Oct4 and 
Sox2 (Lim et al., 2007). Interestingly, a Zic3 binding peak was identified on the 
Nanog promoter. However, apart from this report, there is no evidence that Zic3 
is a direct transcriptional regulator. Members of the Zic family were first described 
as putative transcription factors based on their zinc finger domains, which are 
highly similar to those of the well-studied Gli family of transcription factors. 
However, Zic family member have only been shown to bind Gli target DNA 
recognition sequences in vitro, albeit with much lower affinities (Mizugishi et al., 
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2001). Hence, it has been suggested that Zic3 does not bind directly to DNA but 
acts as a transcriptional coactivator of transcriptional regulation through 
interaction with Gli or other proteins that directly contact DNA. Here, I identified a 
Zic3 consensus binding motif 5’-CC[T/C/A]GG[T/A]C[T/G/A]-3’ which is also 
found on the Nanog promoter (Figure 18,19). Similar to the previously reported 
Zic binding motif 5’-GGGTGGTC-3’ (Mizugishi et al., 2001), this putative motif is 
also rich in guanine (G) and cytosine (C). However, the dissimilarity in the two 
sequences indicates that Zic3 has a unique binding motif and is not a mere 
transcriptional coregulator as previously suggested. The binding affinity of the 
putative Zic3 consensus binding motif reported here (Kd 3 nM) is much higher 
than that reported by Mizugishi et al (Kd 71 nM) (Figure 19). This binding motif is 
highly specific and this is evidenced by the loss of binding when the motif is 
mutated albeit maintaining the same ATGC composition (Figure 20). This 
advocates that Zic3 is capable of binding DNA independently in the absence of 
Gli. Therefore, this also proves that Zic3 directly binds to the Nanog promoter 
with high affinity in a sequence-specific fashion. In addition, I showed that Zic3 is 
necessary for transcriptional activation of Nanog in ES cells, advocating that Zic3 
directly binds and activates transcription of Nanog (Figure 21). Since Nanog is a 
repressor of endodermal specification (Chen et al., 2006), and depletion of Zic3 
results in upregulation of endodermal markers (Lim et al., 2007), Zic3 may 




In the vicinity of the Zic3 binding site on the Nanog promoter, previously 
characterized binding motifs of Oct4, Sox2, Esrrb and n-Myc were also identified 
in silico (Lim et al., 2010) (Figure 22). I searched for these binding motifs in the 
top 1000 Zic3 binding peaks in mouse ES cells. Interestingly, Sox2 motif 
consistently occurs adjacent to the Zic3 binding motif. 2% of the top 1000 Zic3 
peaks consistently showed a Sox2 binding motif in proximity (10 bp) (Figure 23). 
Similar to Zic3, Sox2 is a transcription factor that is involved in transcriptional 
regulation in diverse development process, and how Sox2 proteins regulate 
transcription in a lineage-specific fashion remains unclear. However, partners of 
Sox2 in the transcriptional regulation in distinct developmental contexts have 
been identified. For instance, Sox2 cooperates with Oct4 to regulate fibroblast 
growth factor-4 (Fgf4) (Ambrosetti et al., 1997; Ambrosetti et al., 2000; Yuan et 
al., 1995) and undifferentiated embryonic cell transcription factor-1 (Utf1) 
(Fukushima et al., 1998; Okuda et al., 1998) in ES cells. Sox2 cooperates with 
Pax6 in the transcription of –crystalline (Kamachi et al., 2001; Kondoh et al., 
2004) in lens development. Sox2 also cooperates with Brn1/2/4 and Oct-6 to 
activate transcription of Nestin in neural stem/progenitor cells (Josephson et al., 
1998; Tanaka et al., 2004). Further biochemical analysis of the binding showed 
that both Zic3 and Sox2 bind additively to common targets (Figure 24,25). Here, I 
report that Zic3 is a co-DNA-binding partner of Sox2. When both Zic3 and Sox2 
are allowed to interact with DNA, both binary (Zic3/DNA or Sox2/DNA) and 
ternary complexes (Zic3/Sox2/DNA) are formed. This suggests that the 
interaction of Zic3 and Sox2 with DNA is additive, and Zic3 and Sox2 are capable 
 88 
of binding independently to the Zic3 and Sox2 binding motifs, respectively. If the 
interaction is cooperative, I would expect more ternary complex formed than 
binary complex. If the interaction is competitive, I would only see binary complex 
of either Zic3/DNA or Sox2/DNA which can be resolved in our assay due to their 
different mobility. Although the results suggest that Zic3 and Sox2 interaction is 
additive, it is possible that the HisMBP tag at the N-terminus of Zic3-DBD may 
interfere with direct binding to Sox2 for cooperative binding to DNA. 
Nevertheless, I showed that binding of both Zic3 and Sox2 to the Nanog 
promoter is necessary for transcriptional activation of Nanog in ES cells (Figure 
26). In addition, depletion of either Sox2 or Zic3 can be rescued by 
overexpression of Zic3 or Sox2, respectively. This suggests that Zic3 may co-
bind and co-regulate targets genes with Sox2 in ES cells to maintain 
pluripotency. This is a novel interaction in ES cells that supports our hypothesis 
that Zic3 partners with other transcription factors to co-regulate transcription in a 
lineage-specific fashion in the developmental context.  
 
LIF is required to maintain mouse ES cell pluripotency. To this end, maintenance 
of pluripotency in the absence of LIF through genetic manipulation is possible 
with overexpression of Nanog, Stat3 and Erk receptor (Boeuf et al., 1997; Mitsui 
et al., 2003; Ying et al., 2008). Neither overexpression of Oct4 nor Sox2 is able to 
maintain pluripotency without LIF. Since, Zic3 is a direct activator of Nanog, it is 
intuitive to examine whether overexpression of Zic3 is able to maintain 
pluripotency. Unfortunately, Zic3 is necessary but insufficient to maintain 
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pluripotency in the absence of LIF. Intriguingly, overexpression of Zic3 
accelerates differentiation (Figure 27,28) and precludes endodermal specification 
(Figure 29) and may therefore enhance mesodermal and ectodermal 
specification as suggested previously in Chapter 3. This postulation may seem 
counterintuitive as transcription factors involved in pluripotency should not be 
enhancing lineage specification. Although the current model of pluripotency 
suggests that pluripotency factors repress differentiation and depletion of these 
factors induces differentiation, many pluripotency factors have also been shown 
to specify lineage differentiation (Loh and Lim, 2011). For instance, 
overexpression of Oct4 induces mesodermal specification (Niwa et al., 2000) and 
overexpression of Sox2 induces neuroectoderm specification (Kopp et al., 2008). 
Therefore, similar to Oct4 and Sox2, aberration in the dosage of Zic3 impairs 
pluripotency. Intriguingly, aberration in the dosage of Zic3-target gene Nanog, 
which is one of the core transcription factors, does not impair pluripotency. This 
is in line with a model proposed recently. The authors proposed that these 
pluripotency factors are inherent lineage specifiers and they function to drive ES 
cell differentiation to a particular lineage while inhibiting mutually exclusive 
lineages (Loh and Lim, 2011). As a result, pluripotency is maintained out of 
competition of these pluripotency factors directing differentiation to opposing 
lineages. Therefore, together with the embryonic expression pattern and 


















CHAPTER 5:  







I have reiterated that Zic3 is involved in a wide-array of developmental 
processes. From Gene Onthology (GO) analysis of the Zic3-directly regulated 
genes identified in Chapter 2, results suggest that Zic3 is involved in (1) 
pluripotency by transcriptional-activation of negative regulators of differentiation, 
(2) transcriptional-activation of reproductive system development which includes 
germ cells, (3) transcriptional-activation of mesodermal morphogenesis, the 
mesoderm-derived skeletal system, and the corresponding transcriptional-
repression of late development, and finally (4) transcriptional-activation of early 
nervous system development, and the corresponding transcriptional-repression 
of late development. From the GO analysis of regions co-occupied by Zic3 and  
other pluripotent factors in Chapter 3, results suggest that (1) Zic3 works with 
pluripotent factors Oct4, Sox2, Nanog, Tbx3 and Smad1 to maintain pluripotency 
and drive early development, (2) Zic3 works with Stat3 and E2f1 for 
haematopoietic system development which is of mesodermal origin, (3) Zic3 
works with Nr5a2 and Esrrb for cardiovascular system and kidney development 
which is of mesodermal origin, (4) Zic3 works with Tcfcp2l1 for kidney 
(mesodermal) and nervous system development (neuroectodermal), and finally 
(5) Zic3 alone specifies skeletal system development (mesodermal) and nervous 
system development (neuroectodermal). Therefore, I sought to investigate 
whether Zic3 is indeed involved in these developmental processes. In this 
chapter, I show that Zic3 is required in germ cell development, enhances 
cardiomyocyte specification as well as neuroectodermal specificiation.   
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5.2. Results 
5.2.1. Zic3 is required in germ cell development 
GO analysis of Zic3-directly activated genes enriched for reproductive system 
development (Figure 11). On closer examination, some of these genes such as 
Nr0b1 and Nanog have been shown to be involved in germ cell development. 
Nanog is expressed in the mouse germ cell (Yamaguchi et al., 2005) and 
regulates migration of the primordial germ cells (Sanchez-Sanchez et al., 2010). 
As I had shown earlier that Zic3 is a direct activator of Nanog, I proceeded to 
compare the expression of Zic3 in female and male embryonic germ cells as well 
as male gonads to that of Nanog and Oct4. These expression data were taken 
from GEO database (GSE23322). Interestingly, Zic3 had a similar expression 
profile as that of Nanog but not Oct4 (Figure 30). However, at female E15.5 and 
male E17.5 onwards, Zic3 expression is higher than that of Nanog. Therefore, 
this raised the question of whether Zic3 is required in germ cell development. A 
collaborator from Vladimir Korzh’s group (Institute of Molecular and Cell Biology) 
performed morpholino-knockdown of zic3 in zebrafish embryos. Germ cell 
development was assessed by probing for vasa which is a germ cell marker. In 
wildtype embryos, expression of vasa can be detected at 24 hours post 
fertilization (hpf) in the germinal ridges (Figure 31A). Expression of vasa 
becomes stronger at 48 hpf (Figure 31B). In the mutants, expression of vasa is 
detected at 24 hpf albeit more disperse in the germinal ridges (Figure 31C). 
Interestingly, expression of vasa was observed in the anterior central nervous 
system of the embryo (Figure 31Ca-b). At 48 hpf, reduced vasa expression was 
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observed (Figure 31D). The disperse expression of vasa and ectopic expression 






Figure 30. Pre- and post-natal expression of Oct4, Nanog and Zic3 in female and male 
embryonic germ cells, and male gonads. The expression data was obtained from GEO 







24hpf WT 48hpf WT 
24hpf zic3 MO 48hpf zic3 MO 
24hpf zic3 MO 24hpf zic3 MO 
Figure 31. Depletion of Zic3 impairs germ cell migration. Expression of vasa in germinal 
ridges of embryonic zebrafish upon morpholino-knockdown of zic3 (by Igor Kondrychyn from 
Vladimir Koch’s group in IMCB). In the control experiment, vasa expression is observed in the 
germinal ridges which are in the body cavity at the junction of the thick and extended yolk at 
(A) 24 hpf and (B) 48 hpf. In contrast, vasa expression is germinal ridges in morphant cells are 
dispersed at (C) 24 hpf. (Ca-b) Ectopic appearance of vasa in the anterior central nervous 
system (boxed in C).  (D) At 48 hpf, germinal ridges are reduced in morphant embryos. Arrows 
represent germinal ridges. WT, wildtype; MO, morpholino; hpf, hours post fertilization. 
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5.2.2. Zic3 enhances cardiomyocyte differentiation 
 
In early embryos, Zic3 is expressed in the mesoderm (Nagai et al., 1997). Zic3 
mutant models exhibit abnormalities corresponding to cells derived from the 
mesoderm - cardiovascular system and skeletal system (Carrel et al., 2000; 
Klootwijk et al., 2000; Purandare et al., 2002). In Chapter 2 and 3, GO analysis of 
Zic3-regulated genes and Class II,IV,V,VII Zic3-bound genomic loci also enriched 
for developmental pathways derived from mesoderm. Based on these findings, I 
hypothesized that Zic3 regulates mesodermal specification. To prove this 
hypothesis, I overexpressed Zic3 and assayed for cardiomyocyte differentiation. 
Cardiomyocytes are one of the primary cell types derived from the mesoderm. 
The cardiomyocyte differentiation protocol using the P16CL6 cell line is efficient, 
straightforward and well-established. P19CL6 is an embryonal carcinoma cells 
line engineered with a GFP reporter gene under the control of a cardiomyocyte-
specific gene promoter (MLC-2v) (Moore et al., 2004). Zic3 was overexpressed in 
these cells using a Zic3-overexpression construct (Figure 32A) and subjected to 
differentiation one day post-transfection. A corresponding empty vector was used 
in the control experiment. Three weeks post-transfection, I quantitated the 
number of EGFP-positive and beating colonies of cardiomyocytes. Interestingly, 
overexpression of Zic3 had a three-fold increase in GFP-positive beating 
colonies (Figure 32Bb,C) compared to the control (Figure 32Ba,C). This indicated 
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Figure 32. Zic3 enhances cardiomyocyte differentiation. (A) Validation of Zic3 
overexpression in P19CL6. (B) GFP-positive beating colonies after three weeks of 
differentiation. (a) An empty vector was transfected into P19CL6 in the control experiment. 
(b) Zic3-overexpression construct was transfected into P19CL6. (C) GFP-positive and 
beating colonies were quantitated three weeks post-transfection.  Scale bar represents 200 
m. Each experiment was performed with three biological replicates and three technical 
replicates. Error bars are representative of standard error. 
P < 0.004 
C 
A B 
P < 0.05 
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5.2.3. Zic3 enhances neuroectodermal specification 
In addition to expression in the embryonic mesoderm, Zic3 is also expressed in 
neuroectoderm (Nagai et al., 1997). Zic3 mutant models exhibit abnormalities in 
the nervous system which is derived from the neuroectoderm (Carrel et al., 2000; 
Klootwijk et al., 2000; Purandare et al., 2002). In Chapter 2 and 3, GO analysis of 
Zic3-regulated genes and Class V,VII Zic3-bound genomic loci are also enriched 
for biological pathways derived from neuroectodermal specification. Based on 
these findings, I hypothesized that Zic3 regulates neuroectodermal specification.  
 
5.2.3.1. Zic3 expression is upregulated upon neuroectodermal 
differentiation 
I have reported in Chapter 2 that Zic3 directly activates genes involved in early 
nervous system development and represses genes involved in late development. 
Therefore, I examined whether the expression profile of Zic3 in mouse ES cells 
subjected to neuroectodermal differentiation corresponds to this finding. 
Neuroectodermal differentiation was performed in adherent monolayer culture 
conditions (Ying et al., 2003b). Coincidentally, Zic3 expression was sharply 
upregulated during the initial phase of neuroectodermal differentiation and 







































Figure 33. Relative expression of Zic3 transcripts upon neuroectodermal differentiation. 
E14 mouse ES cells were subjected to neuroectodermal differentiation for 12 days. Zic3 
mRNA levels were determined by qPCR every two days. Each experiment was performed 
with three biological replicates and three technical replicates. Error bars are representative 
of standard error. *P<0.05. Paired t-test was performed by comparing cells at each time 




5.2.3.2. Overexpression of Zic3 accelerates neural rosette formation and 
produces more neuronal cells 
To temporally control Zic3 expression during differentiation, I used an inducible-
Zic3 overexpression ES cell line that was previously generated in the lab 
(Inducible-Zic3 #1 and #2) (Lim et al., 2010). These clonal lines overexpress Zic3 
in response to doxcycline treatment (Figure 34). To investigate the effect of Zic3 
overexpression in neuroectodermal monolayer differentiation, I subjected the 
inducible-Zic3 ES cells to neuroectodermal differentiation (Ying et al., 2003b) and 
induced Zic3 overexpression throughout the neuroectodermal differentiation. 
Interestingly, neural rosettes were formed earlier (day 6) when Zic3 was 
overexpressed (Figure 35Ab,Bb) as compared to the control experiment in which 
Zic3 was not overexpressed (Figure 35Aa,Ba). At a later phase of differentiation 
to neuroectoderm (day 12), a greater number of cells with neuronal-like 
projections were observed when Zic3 was overexpressed (Figure 35Ad,Bd) as 
compared to the control experiment in which Zic3 was not overexpressed (Figure 
35Ac,Bc).  
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Figure 34. Inducible-Zic3 clonal lines are responsive to doxycycline during neuroectodermal 
differentiation. Both (A) inducible-Zic3 clonal line #1 and (B) inducible-Zic3 clonal line #2 express 
exogenous Zic3 during differentiation upon doxycycline induction. Inducible Zic3 constructs were 
tagged with haemagglutinin (HA). Western analysis was performed with HA-specific antibody. Actin 
B was used as loading control. 
 









































Figure 35. Overexpression of Zic3 accelerates formation of neural rosettes in the early phase and 
increases neuronal cells in late phase of differentiation. (A) Inducible-Zic3 #1 and (B) inducible-Zic3 
#2 clonal lines were subjected to neuroectodermal differentiation. (b,d) Zic3 overexpression was 
induced throughout differentiation. (a,c) As a control, Zic3 overexpression was not induced in the 
clonal lines. Scale bar represent 200 m. Arrowhead shows neural rosettes formed in day 6 of 











5.2.3.3. Temporally-controlled induction of Zic3 overexpression produces 
more neuronal cells 
My earlier findings suggested that Zic3 may have a late repressive role in 
nervous system development. This is further advocated by the expression of 
endogenous Zic3 during neuroectodermal differentiation where an early 
upregulation and late downregulation of Zic3 was observed. Therefore, I pulsed 
Zic3 overexpression to investigate the effect of varying duration of Zic3 
overexpression on neuronal differentiation. I induced Zic3 overexpression for 2, 
4, 6, 8, 10 or 12 days and assayed for the expression of pan-neuronal marker 
Tuj1/-tubulin III at day 12 of the differentiation protocol. Overexpression of Zic3 
during differentiation results in more cells expressing pan-neuronal marker Tuj1 
(Figure 36Ab-g,Bb-g) when compared to the control experiment in which Zic3 
was not overexpressed (Figure 36Aa,Ba). However, the greatest number of Tuj1-
expressing cells was yielded when Zic3 overexpression was switched on for 8 
days of differentiation and switched off thereafter. Notably, sustained 
overexpression of Zic3 beyond 8 days appears to reduce the enhancement in 
production of Tuj1-positive cells (Figure 36Ae-g,Be-g,C,D). This indicated that 
overexpression of Zic3 does enhance neuroectodermal differentiation. However, 
overexpression of Zic3 in the later phase of differentiation appears to have an 
inhibitory effect on neuroectodermal differentiation. 
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Inducible-Zic3 #1 Inducible-Zic3 #2 
A B C 
D 
Tuj1/DAPI 
Figure 36. 8 days of doxycycline-induction 
of Zic3 overexpression yields more 
neuronal cells. (A) Inducible-Zic3 #1 and 
(B) inducible-Zic3 #2 were subjected to 12 
days of neuroectodermal differentiation, 
and immunostained for Tuj1 (red) and DAPI 
(blue) on the 12
th
 day of differentiation. (a) 
No Zic3 overexpression was induced in the 
control. Zic3 overexpression was induced 
for (b) 2 days, (c) 4 days, (d) 6 days, (e) 8 
days, (f) 10 days, or (g) 12 days. (C)  
Histogram of clonal lines treated with 0-12 
days of doxycyline-induction, and subjected 
to flow cytometry for Tuj1-positive cells. (D) 
Percentage of cell population expressing 
Tuj1 based on analysis of the flow 
cytometry result. Scale bar represents 200 
m. Each experiment was performed with 
three biological replicates and three 
technical replicates. Error bars are 
representative of standard error. *P<0.05. 
Paired t-test was performed by comparing 
cells induced with 8 days of doxycycline to 




 Scale bar represent 200 m. 





5.2.3.4. Overexpression of Zic3 accelerates expression of Nestin, and 
increases yield of Nestin- and Tuj1-expressing cells 
To understand whether the observed enhancement in production of Tuj1-
expressing neuronal cells is a result of promotion of differentiation of ES cells to 
neural progenitors, enhanced proliferation of neural progenitors, or accelerated 
differentiation of neural progenitors into neuronal cells, I tracked the 
differentiation progress of the Zic3 overexpressing cell lines. I induced Zic3 
overexpression for 8 days and assayed for neural progenitor marker, Nestin 
during the early phase of differentiation (day 0-6), followed by the pan-neuronal 
marker Tuj1 during the later phase (day 6-12) (Figure 37). Notably, expression of 
neural progenitor marker Nestin was initiated earlier in response to 
overexpression of Zic3. Upon Zic3 overexpression, Nestin was expressed on day 
3 of differentiation. In constrast, Nestin is only expressed on day 4 of 
differentiation without Zic3 overexpression (Figure 38). In addition, more Nestin-
expressing cells were also observed in Zic3 overexpressing cells (Figure 38). 
Expression of Tuj1 was initiated in both inducible-Zic3 clonal lines on the sixth 
day of differentiation with or without induction of Zic3 overexpression. However, 
there were more cells expressing Tuj1 on day 6 of differentiation onwards with 
Zic3 overexpression as compared to the control experiment in which Zic3 was 
not overexpressed (Figure 39A,B). Flow cytometry analysis showed that 
overexpression of Zic3 doubled the production of Tuj1-expressing neuronal cells 
(Figure 40). Hence, our findings suggested that overexpression of Zic3 
accelerated the differentiation of ES cells into Nestin-positive neural progenitors 
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but does not accelerate the differentiation into Tuj1-positive neuronal cells. 
Instead, Zic3 overexpression promotes expansion of the Nestin-positive neural 
progenitors. Eventually, these expanded Nestin-positive neural progenitors 
differentiate into Tuj1-positve neuronal cells, thus giving a two-fold enhancement 






Figure 37. Schematic of the neuroectodermal differentiation. Inducible-Zic3 clonal lines were 
subjected to neuroectodermal differentiation for 12 days. Zic3 overexpression was induced with 
doxycycline (dox) for 8 days before excluding dox from the neuroectodermal differentiation media. In 
the control experiment, Zic3 was not overexpressed. Differentiation was assayed by immunostaining 


















Inducible-Zic3 #1 Inducible-Zic3 #2 
A B 
Figure 38. Overexpression of Zic3 accelerates differentiation to neural progenitors and increases 
yield of neural progenitors. (A) Inducible-Zic3 #1 and (B) inducible-Zic3 #2 clonal lines were 
subjected to neuroectodermal differentiation in the presence of doxycycline induction. In the control 
experiment, there was no doxcycline induction in the neuroectodermal differentiation. Cells were 
immunostained for neural progenitor marker Nestin (green) and DAPI (blue) on day 2, 3, 4, 5 and 6 












Figure 39. Overexpression of Zic3 does not accelerate Tuj1 expression but yields more Tuj1-
expressing cells. Neuroectodermal differentiation of (A) Inducible-Zic3 #1, (B) inducible-Zic3 
#2. In the control experiment, there was no doxycycline induction in the neuroectodermal 
differentiation. Cells were immunostained for pan-neuronal marker Tuj1 (red) and DAPI (blue) 
on day 0, 6, 8, 10 and 12 of the differentiation. Scale bar represents 200 m. 
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Control           Zic3 O/E (+ dox)          No Zic3 O/E (-dox) 
* 
** 
Figure 40. Overexpression of Zic3 yields more Tuj1-expressing cells. Histogram of (A) 
Inducible-Zic3 #1 and (B) inducible-Zic3 #2 treated with 10 and 12 days of neuroectodermal 
differentiation in the presence of doxycycline induction for 8 days and subjected to flow 
cytometry for detection of Tuj1-positive cells (green). This was compared to clonal lines not 
subjected to doxycycline induction (blue). Cells were not incubated with primary antibody as a 
control (red). (C) Percentage of cell population expressing Tuj1 based on analysis of the flow 
cytometry result. Each experiment was performed with three biological replicates and three 
technical replicates. Error bars are representative of standard error. *P<0.008; ** P<0.009. 
Paired t-test was performed by comparing cells induced with doxcycline to the corresponding 










5.3.1. Zic3 is required in germ cell migration 
During the early postimplantation stage, primordial germ cell (PGC) precursors 
are formed from the proximal epiblast upon reception of signals from the 
extraembryonic ectoderm. They continue to divide and migrate, eventually 
arriving at the developing gonads. The molecular mechanism regulating germ 
cell fate determination remains to be deciphered. Intriguingly, ES cell core 
transcription factors Oct4 and Nanog have been implicated in germ cell 
development. Oct4 is a known marker of PGCs. It is expressed in nascent PGCs 
and is required for their survival (Kehler et al., 2004; Scholer et al., 1990; Yeom 
et al., 1996). Nanog is also expressed in the proliferating germ cells and is 
required for the migration of germ cells (Sanchez-Sanchez et al., 2010; 
Yamaguchi et al., 2005). Here, I show that similar to Oct4 and Nanog, Zic3 is 
expressed in pre- and post-natal germ cells. Zic3 exhibits an expression profile 
that is more similar to that of Nanog than Oct4 (Figure 30). This suggests that 
Zic3 may be involved in germ cell development in a fashion that is similar to 
Nanog (germ cell migration) rather than Oct4 (germ cell survival). Indeed, this is 
advocated by the aberrant expression of the germ cell marker, vasa, upon 
depletion of Zic3 in zebrafish (Figure 31). This phenotype is consistent with the 
disruption of the Cxcl12-Cxcr4-Cxcr7 pathway which is known to guide the 
collective migration of germ cells (Knaut et al., 2003). It was previously reported 
that Nanog orchestrates germ cell migration by regulating Cxcr4 in medaka 
(Sanchez-Sanchez et al., 2010) . Since Zic3 is a direct activator of Nanog, Zic3 
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may be directing germ cell migration through Nanog. It was previously reported 
that in mouse, hemizygous males with deletion of one Zic3 allele exhibit reduced 
fertility (Carrel et al., 2000) which may be attributed to the aberrant germ cell 
migration. However, this Zic3-deleted mouse model, Bent tail, is one of the few 
Zic3-null or mutant mouse models which exhibited this phenotype. Nevertheless, 
this is a novel role for Zic3, and the new addition of Zic3 to the pool of known 
pluripotent factors implicated in germ cell development suggests that pluripotent 
factors may be involved in maintaining pluripotency of the germ lineage since 
PGCs are embryonic cell types that possess pluripotent capabilities. Studies 
have shown that mouse embryonic germ cell lines can be established by 
isolating PGCs and culturing them on feeder cells. These embryonic germ cell 
lines can self-renew indefinitely, and possess differentiating capacity that is 
indistinguishable from ES cells (Rohwedel et al., 1996). These cells can also 
contribute to the embryo proper when injected into a mouse blastocyst (Stewart 
et al., 1994). Therefore, it is plausible that Zic3, a pluripotency regulator, also 




5.3.2. Zic3 enhances mesoderm-derived cardiomyocyte specification 
Zic3 mutations have been associated with X-linked heterotaxy, a result of 
aberrant left-right patterning during embryogenesis. Complex congenital 
cardiovascular malformation is one of the consequences of aberrant left-right 
patterning. Therefore, Zic3 deficiency or mutation is also associated with 
cardiovascular malfunction, possibly as a consequence of aberrant left-right 
patterning. However, reports of patients presenting congenital heart disease 
associated with Zic3 mutations but independent of left-right patterning 
abnormality suggested otherwise (Gebbia et al., 1997; Megarbane et al., 2000; 
Ware et al., 2004). Notably, congenital heart disease which is the most common 
cause of infant mortality attributable to developmental defects, have a multi-
factorial etiology. The isolated congenital heart disease caused by Zic3 
deficiency or mutation is one of the few known monogenic causes of congenital 
heart disease. The role of Zic3 in cardiovascular disorders independent of left-
right patterning has been advocated by (1)  the  downregulation of cardiac-
specific genes upon depletion of Zic3 and (2)  defective myocardial development 
without heart looping defects, which is associated with abnormal left-right 
patterning, in Zic3-null mice (Zhu et al., 2007). Here, my results corroborate the 
authors’ findings. I showed that overexpression of Zic3 enhances cardiomyocyte 
differentiation by more than two-fold (Figure 32). Cardiomyocytes are one of the 
primary cell types derived from the mesoderm. I have described in previous 
chapters that Zic3 directly regulates genes that are involved in development of 
various systems (cardiovascular, skeletal, kidney and haematopoietic) of the 
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mesodermal lineage. The expression of Zic3 in the embryonic mesoderm may 
thus be involved in the determination of these cell fates from the mesoderm. 
Therefore, the two-fold enhancement of cardiomyocyte differentiation upon 
overexpression of Zic3 may possibly be attributed to the enhanced differentiation 
of ES cells to mesoderm or enhanced differentiation of mesoderm to 
cardiomyocytes.  Zhu et al also reported that Zic3 interacts with serum response 
factor (SRF) in precardiac mesoderm and the developing heart (Zhu et al., 2007). 
SRF has been shown to be essential for mesoderm formation during mouse 
embryogenesis (Arsenian et al., 1998). SRF-null mice exhibit misfolded ectoderm 
and endoderm, but no mesoderm. It would thus be interesting to study whether 





5.3.3. Zic3 enhances neuroectodermal specification 
Neuroectodermal differentiation is primarily dependent on three well-studied 
pathways, namely, BMP-inhibition, Fgf signaling and calcium induction (Aruga 
and Mikoshiba, 2011). Zic family members are thought to be downstream targets 
of all three pathways. Previous studies in Xenopus and zebrafish have shown 
that blockade of BMP results in expansion of zic3 (Grinblat and Sive, 2001; 
Nakata et al., 1997). Blockage of FGF signaling results in repression of zic3 
expression (Marchal et al., 2009). Overexpression of calcium-induced gene 
xPRMT1b in the Xenopus neuroectoderm upregulates zic3 expression (Batut et 
al., 2005). Zic3 is expressed prior to other proneural genes, and studies have 
shown that expansion of zic3 results in upregulation of proneural genes (Nakata 
et al., 1997). Together, these studies suggest that Zic3 has an early 
neuroectoderm specification role. On top of that, I found that Zic3 directly 
activates genes involved in early nervous system development while repressing 
genes involved in late development. This is advocated by the endogenous 
expression of Zic3 during neuroectodermal differentiation where Zic3 is initially 
upregulated but gradually downregulated as differentiation proceeds (Figure 33). 
Indeed, overexpression of Zic3 enhances neuroectoderm specification (Figure 
35). Further analysis showed that early overexpression of Zic3 generates more 
neuronal cells compared to extended period of Zic3 overexpression (Figure 36). 
Interestingly, overexpression of Zic3 accelerates differentiation of ES cells to 
neural progenitors (Figure 38) but not differentiation of neural progenitor cells to 
neuronal cells (Figure 39). Instead, Zic3 promotes expansion of neural 
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progenitors which gives rise to more neural progenitors and eventually more 
neuronal cells (Figure 40). This therefore supports the model that Zic3 activates 
early nervous system development. Zic3 closely-related family members, Zic1 
and Zic2, were also reported to have a late repressive role in neuronal 
differentiation (Aruga et al., 2002a; Aruga et al., 2002b). 
 
This is the first reported instance of Zic3 as a molecular switch to enhance 
neuroectodermal differentiation from mouse ES cells in vitro. Interestingly, 
previous studies have shown that overexpression of Sox2 also enhances 
neuroectodermal differentiation. In Chapter 4, I showed that there is a plausible 
redundant role of Zic3 and Sox2 in transcriptional regulation in ES cells. The 
ability of Zic3 and Sox2 to positively-influence lineage choice of mouse ES cells 
towards neuroectoderm, suggests that Zic3 and Sox2 may possibly co-regulate 
transcriptional regulation in neuroectoderm. It would therefore be interesting to 























Zic3 has been implicated in a wide-array of development processes, namely, left-
right patterning, cardiovascular development, skeletal development and nervous 
system development. In addition, Zic3 is also an essential ES cell regulator. The 
ability of Zic3 to participate in such diverse developmental processes can be 
attributed to several parameters. First, Zic3 binds both enhancers and promoters 
of genes, thereby permitting dynamic gene regulation. Second, Zic3 is both a 
transcriptional activator and repressor. Zic3 directly activates genes involved in 
negative-regulation of differentiation which supports its role in pluripotency. Zic3 
also directly activates genes involved in mesoderm morphogenesis, early 
skeletal development, early nervous system development and the reproductive 
system. The development of these systems is impaired when Zic3 is deficient or 
mutated. Zic3 directly represses genes involved in late development of the 
cardiovascular system, reproductive system and nervous system. The dual 
function of Zic3 as a transcriptional activator and repressor was demonstrated in 
the neuroectodermal differentiation model where Zic3 is upregulated in the early 
phase of differentiation to drive differentiation into progenitors and promote 
expansion of the progenitors. Third, Zic3 recruits specific factors for regulation of 
distinct biological processes. Zic3 co-binds DNA with p300 for transcriptional 
activation, and Suz12 for transcriptional repression. Additionally, Zic3 co-binds 
genomic regions with ES cell regulators Oct4, Sox2, Nanog, Smad1 and Tbx3 to 
regulate pluripotency. Zic3 co-binds genomic regions with Stat3 and E2f1 to 
regulate haematopoietic system development. Zic3 co-binds genomic regions 
with Nr5a2 and Esrrb to regulate cardiovascular system and kidney development. 
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Zic3 co-binds genomic regions with Tcfcp2l1 to regulate nervous system and 
kidney development. Zic3 alone binds genes involved in the skeletal and nervous 
system, poising them for activation upon reception of the right development cues. 
These developmental pathways are largely derived from the mesoderm and 
neuroectodermal lineage. The similarity of the binding profile of Zic3 to the ES 
cell core transcription factors Oct4, Sox2 and Nanog indicates that Zic3 is an 
integral component of the ES cell regulatory network. Additionally, Zic3 directly 
activates Nanog. Therefore, activation of Nanog by Zic3 may account for the 
Zic3-enhanced reprogramming of somatic cells to induced pluripotent stem cells 
through synergistic re-activation of the ES cell program. Similar to Nanog, Zic3 is 
required for germ cell migration. However, unlike Nanog but more similar to Oct4 
and Sox2, the dosage of Zic3 influences cell fate determination. Overexpression 
of Zic3 precludes endodermal specification and enhances cardiomyocytes 
(mesodermal) and neuroectodermal specification thereby indicating that Zic3 is 
an early lineage specifier and therefore controls cell fate decision (Figure 41). 
This is thus useful in the efficient generation of specific cell types in vitro by 
genetic manipulation of Zic3. 
 
The findings presented in this report demonstrate that the pluripotency regulator 
Zic3 is also a lineage specifier. Intuitively, a pluripotency regulator should be 
actively promoting pluripotency instead of promoting lineage specification. 
However, overexpression of several pluripotency transcription factors have been 
shown to promote differentiation into specific lineages (Figure 42) (Loh and Lim, 
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2011). Furthermore, even though ES cells can be cultured indefinitely in a 
pluripotent state in vitro, pluripotency is a transient phase in vivo. Therefore, 
pluripotency transcription factors are lineage specifiers actively promoting their 
specific lineages, and pluripotency is a precarious resultant state that is elicited 
by the conflicting interest of these transcription factors. Upon reception of the 
right signals, the differentiation program dominates. Nevertheless, an intricate 
balance of these pluripotency transcription factors is essential to maintain a 
pluripotent state, and loss of this balance results in lineage specification. Zic3 is 








Figure 40. Model of Zic3-regulation in the control of cell fate decisions. Genes directly 
activated and repressed by Zic3 were identified from the previously reported microarray 
expression profile analysis of Zic3-knockdown and Zic3-overexpression (Lim., 2008). These 
genes were submitted to gene onthology analysis. Some examples of genes regulated by 
Zic3 in pluripotency, germ cell, mesodermal, neuroectodermal and endodermal specification 




Figure 42. Pluripotency transcription factors are lineage specifiers. Zic3-associated lineage 




















CHAPTER 7:  





7.1. Chromatin immunoprecipitation and validation 
Mouse ES cells were grown to 70% confluency on 500 cm2 dishes for each 
immunoprecipitation. Cells were fixed with 1% formaldehyde for 10 mins at RT. 
The reaction was quenched with 125 mM glycine. Cells were then washed thrice 
in buffer containing 20 mM Tris pH 7, 0.15 M sodium chloride and 1 mM EDTA 
pH 8. Nuclear fraction was harvested after the following lysis steps, each step 
completed: (1) 15 minutes incubation in Buffer 1 containing 10 mM Tris pH 8, 
0.25% Triton X-100, 10 mM EDTA pH 8, 0.1 M sodium chloride, and centrifuged 
at 1000 g for 15 minutes, (2) 30 minutes incubation in Buffer 2 containing 50 mM 
HEPES-KOH pH 7.5, 150 mM NaCl, 2 mM EDTA, 1% Triton-X100, 0.1% sodium 
deoxycholate, 1% sodium dodecyl sulfate, followed by centrifugation at 16,000 g 
for 30 minutes, and (3) 30 minutes incubation in Buffer 3 containing 50 mM 
HEPES-KOH pH 7.5, 150 mM NaCl, 2 mM EDTA, 1% Triton-X100, 0.1% sodium 
deoxycholate, 0.1% sodium dodecyl sulfate, followed by centrifugation at 16,000 
g for 30 minutes. Chromatin pellet was then sonicated in to an average size of 
500 bp, in Buffer 3. Immunoprecipitation was performed using 10 µg of Zic3 
antibody previously generated (Lim et al., 2007). Input DNA was used as control 
for ChIP-seq library preparation. Rabbit IgG (Santa Cruz) was used as control in 
ChIP-seq validation. Antibody was adsorbed onto pre-blocked Protein G 
separose beads (Roche) for 2 hours at RT. Antibody-sepharose bead complexes 
were washed thrice in Buffer 3, pelleted at 1000g for 1 min, and incubated with 
chromatin extract overnight at 4˚C. Immunoprecipitated chromatin extract was 
washed thrice in Buffer 3, pelleted at 1000g for 1 min, and eluted at 68˚C for 30 
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mins in elution buffer containing 50 mM Tris pH 7.5, 10 mM EDTA and 1% SDS. 
Extract was then treated with RNAse at 37˚C for 1 hour, and decrosslinked by 
pronase at 42˚C for 2 hours followed by 68˚C for 6 hours. DNA was purified by 
phenol-chloroform extraction followed by ethanol precipitation. Purified DNA was 
either subjected to ChIP-seq library preparation or quantitative PCR validation.  
For library preparation, ChIP-seq DNA sample prep kit (Illumina) was used 
according to manufacturer’s protocol. Purified DNA was subjected to end-repair 
with Klenow enzyme, T4 DNA polymerase and T4 PNK at 20˚C for 30 min. DNA 
was purified with QIAquick purification kit (Qiagen) according to manufacturer’s 
protocol. 3’-dA overhang was added to the purified blunt-ended DNA fragments 
with Klenow fragment (3’ to 5’ exo minus) at 37˚C for 30 min. DNA was purified 
with QIAquick MinElute kit (Qiagen) according to manufacturer’s protocol. 
Illumina adaptors were ligated to ends of the DNA fragments using DNA ligase at 
25˚C for 15 min. DNA was purified with QIAquick purification kit. Adaptor-ligated 
DNA was PCR amplified using Pfx polymerase (Invitrogen) according to 
manufacturer’s protocol. The thermocycling condition was as follows: Step 1, 
94˚C for 5 min; Step 2, 94˚C for 15 sec, 55˚C for 30 sec, and 60˚C for 68 sec; 
Step 3, repeat Step2 for another 14 cycles; Step 4, hold at 4˚C. DNA was purified 
with QIAquick MinElute kit and further resolved by 2% ultra low range agarose 
gel (Bio-Rad). Adaptor-ligated DNA between size 200 to 300 bp was excised and 
gel purified (Qiagen) according to manufacturer’s protocol. Purified DNA was 
subjected to Solexa sequencing.  
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For ChIP-seq validation, decrosslinked Zic3-immunoprecipitated chromatin and 
IgG-immunoprecipitated chromatin were subjected to real-time quantitative PCR 
using the SYBR green PCR mastermix (Applied Biosystem) according to the 
manufacturer’s protocol. Reactions were loaded in triplicates using 384-well 
plates on the Prism 7900 machine (Applied Biosystem). Refer to Table 5 for the 
list of primers used.   
 
Table 5. List of primers used for validating chromatin immunoprecipitation results. 
Targets Sequence 
Agtrap 5’ AGAAGCCATATGGGAACCCATG 3’ 
 5’ ATTAAATTAGGTCTGCCCCGCC 3’ 
DIIert 5’ GCAGGCCAGAAGCATCGGAAAC 3’ 
 5’ CAGTGGATTCCTCGCTGGGAGG 3’ 
DLL 5’ CCCTCCCCCTATGCCTCTCCTTC 3’ 
 5’ CGGGCTGCAGCCGCAGGTAAAC 3’ 
Fgf5 5’ TCTTGTCTTCCTGGTGGCTCTCGG 3’ 
 5’ TTTCCAAACCCTCCCCACAGGC 3’ 
Jarid 5’ AACCACAAAGGACAATCCATTTTCC 3’ 
 5’ CTCCAAGTCCCAGGCAAGTGTG 3’ 
Klf6 5’ ACAGGGAAACCTGCGGGCACGTTTG 3’ 
 5’ TGTTCCCGGATCCTTCCCTGAC 3’ 
 
 
7.2. Chromatin immunoprecipitation analysis  
Zic3-ChIP data was uploaded to GEO database, ID GSE37889. Binding peaks 
from the Zic3 ChIP-seq data were called using the algorithm, MACS (Zhang et 
al., 2008b), with the following parameters: mfold=32, gsize=1.87E9 and P 
value=1E-5. The consensus binding motif was obtained from the algorithm, 
MEME (Bailey et al., 2006).  
The ChIP-seq data of other ES cell regulators and histone marks were 
downloaded from the GEO database: Oct4, Sox2, Esrrb, Klf4, Nanog, Stat3, 
Smad1, Tcfcp2l1, E2f1, n-Myc, c-Myc, and Zfx, GEO ID GSE11431 (Chen et al., 
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2008); Nr5a2, GEO ID GSE19019 (Heng et al., 2010); REST and Sin3A, GEO ID 
GSE28233 (Yu et al., 2011); Tbx3, GEO ID GSE19219 (Han et al., 2010); Eset, 
GEO ID GSM440256 (Yuan et al., 2009); Ezh2 and Ring1B, GEO ID GSE13084 
(Ku et al., 2008); H3K4me1 and H3K4me2, GEO ID GSE12241 (Mikkelsen et al., 
2007); H3K4me3, GEO ID GSE11172 (Meissner et al., 2008); and H3K27ac, 
GEO ID GSE24164 (Creyghton et al., 2010). Hierarchical clustering of these 
transcription factor binding sites and histone marks was performed on the peaks 
of H3K4me1 and H3K4me2. ChIP-seq data were arranged in tag-counts of 200 
bp bins. Noise was minimized using a smoothing rectangular kernel of 400 bp (2 
bins). The maximum level within 1 kb from the center of H3K4me1/H3K4me2 
peaks was used for hierarchical clustering.     
Transcription factor co-binding patterns was identified using ChIP-seq data 
binned in the form of 200bp bins. Noise was minimized using a smoothing 
rectangular kernel of 400 bp (2 bins). The maximum level within 1 kb of the top 
10,000 Zic3 peaks for each transcription factor was subjected to K-mean 
clustering. The number of classes was decided after testing and finding the 
maximum number of classes to which K-mean clustering (MATLAB) could 
converge in 100 iterations.  
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7.3. Gene-ontology term enrichment 
Functional significance of binding targets or genes was inferred from GREAT 
gene ontology analysis (McLean et al., 2010). Whole genome was used as 
background. Enriched GO terms which had FDR Q-value lower than 0.05 were 
chosen.  
 
7.4. Protein expression and purification 
Mouse Zic3 DNA binding domain (DBD), amino-acid residues 237 – 411 (Swiss-
Prot Q62521), was PCR-amplified using the primers 5’-GGGGACAAGTT 
TGTACAAAAAAGCAGGCTTCGAAAACCTGTATTTTCAGGGCGCCTTCTTCC 
GTTACATGC-3’ and 5’- GGGGACCACTTTGTACAAGAAAGCTGGGTTTAAGA 
TTCATGAACCTTCATGTG-3’. The PCR product was inserted into entry vector 
by Gateway BP reaction (Invitrogen), and recombined into Addgene plasmid 
11085 pDEST-HisMBP (Nallamsetty et al., 2005) by Gateway LR reaction 
(Invitrogen). The expression plasmid was transformed into Escherichia coli BL21 
(DE3) cells (Invitrogen) and cultured at 37°C in Terrific broth supplemented with 
100 g/ml ampicillin and 0.2% glucose. At OD600nm of 0.5-0.7, protein 
expression was induced with 0.5 mM isopropyl-,D-thiogalactopyranoside, and 
cultured at 18°C overnight. Bacterial cell pellet was resuspended in lysis buffer 
(10 mM Hepes pH 7.3, 100 mM NaCl, 30 mM imidazole) and sonicated, and 
centrifuged. The supernatant was incubated with Ni-Sepharose beads (GE 
Healthcare) at 4°C for 2 hours. Protein was eluted with elution buffer (10 mM 
Hepes pH 7.3, 100 mM NaCl, 300 mM imidazole) and contaminating DNA was 
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removed with 0.1% polyethyleneimine in the presence of 1M NaCl. Protein was 
then purified by size-exclusion chromatography using a HiLoad 16/60 Superdex 
200 pg (GE Healthcare) and collected in  10 mM Tris pH 8 buffer containing 100 
mM NaCl. Fractions containing protein were pooled and concentrated to 20 M. 
The protein identity was verified by MALDI-TOF-TOF. The Sox2-HMG protein 
was previously generated (Jauch et al., 2011). 
 
7.5. Electrophoretic mobility shift assay 
Protein was incubated with DNA sequence labeled with Cy5-labelled DNA at 4°C 
for 1 hour in binding buffer (10 mM Tris pH8, 0.1 mg/ml bovine serum albumin, 
50 M ZnCl2, 100 mM KCl, 0.5 mM MgCl2, 10% glycerol, 0.1% NP-40, 2 mM -
mercaptoethanol). Dissociation constant (Kd) was determined by titrating 0-500 
nM (2-fold serial dilution) of protein against 1 nM of Cy5-labelled DNA. The 
reactions were resolved by 10% native Tris-glycine polyacrylamide gel 
electrophoresis. Gels were analysed using Typhoon Scanner (GE Healthcare). 
 
Competition assay was performed by titrating 0-500 nM (2-fold serial dilution) of 
competitor containing either the wildtype or mutated sequences against 1 nM 
probe in the presence of protein at a concentration equivalent to the Kd. In the 
co-DNA binding assay, 0-12.5 nM (2-fold serial dilution) protein was titrated 
against 1 nM probe in either in the presence of the second protein of interest at 
the concentration equivalent to the Kd. 
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7.6. Luciferase reporter assay, shRNA and overexpression constructs 
The Nanog promoter region (428 bp) was PCR-amplified from mouse ES cell 
genomic DNA using primers 5’-atgctagcatcagaggatgccccctaag-3’ and 5’-
atctcgaggtcagtgtgatg gcgaggga-3’. The PCR product was cloned into pGL3-basic 
vector (NheI and XhoI sites) upstream of the firefly luciferase gene (Promega). 
For each luciferase reporter assay, 2x105 E14 mouse ES cells were seeded into 
each well of a 24-well plate. 275 ng of luciferase reporter plasmid, 4 ng of 
plasmid containing Renilla luciferase (pRL-SV40) and 500 ng of either shRNA or 
overexpression constructs were cotransfected into the cell by lipofectamine 2000 
(Invitrogen), 18 hours after seeding. The pRL-SV40 plasmid served as an 
internal control for normalizing the transfection efficiency. Cells were lysed 72 
hours after transfection, and luciferase activity was determined using the dual 
luciferase system (promega), according to the manufacturer’s protocol. Zic3 and 
Sox2 shRNA and overexpression constructs were previously generated (Lim et 
al., 2007; Lim, 2008). Paired t-test was used for statistical analysis. 
 
7.7. RNA extraction, cDNA conversion and quantitative PCR 
Cell pellet was solubilized in TriZol (invitrogen), and RNA was purified using the 
RNeasy kit (Qiagen) according to the manufacturer’s protocol. RNA was treated 
with DNase at 15 mins at RT to remove genomic DNA contaminants after 
introducing sample into the column and prior to washing step in the 
manufacturer’s protocol. 1.5 µg of RNA was used to synthesize cDNA using the 
High Capacity cDNA conversion kit (Applied Biosystems) according to the 
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manufacturer’s protocol. cDNA synthesis was performed at 25˚C for 10 minutes 
followed by 37˚C for 2 hours. cDNA was diluted 10fold in nuclease-free water. 
Real-time qPCR was performed using TaqMan probes where stated (refer to 
Table 6 for list of TaqMan probes), and each reaction consists of 4.5 µl of diluted 
cDNA, 5 µl of TaqMan Universal PCR Master Mix reagent (Applied Biosystems) 
and 0.5 µl TaqMan probe (20x TaqMan Gene Expression Assay Reagents; 
Applied Biosystems). Reactions were performed in triplicates, in 384-well 
reaction plates using the ABI Prism 7900 machine (Applied Biosystems). Paired 
t-test was used for statistical analysis. 
 
 
Table 6. List of TaqMan probes used to access pluripotency and endodermal specification. 
Gene Description 
Zic3 Gene of interest 
Oct4 Pluripotency marker 
Sox2 Pluripotency marker 
Nr5a2 Pluripotency marker 
Sox17 Endodermal marker 
Pdgfra Endodermal marker 
Foxa2 Endodermal marker 
Gata4 Endodermal marker 




7.8. Protein extraction and western analysis 
Cells were scraped off tissue culture dishes in ice-cold PBS. Cells were pelleted, 
resuspended and incubated in RIPA buffer (Thermoscientific) supplemented with 
EDTA-free protease inhibitor (Roche) according to manufacturer’s protocol. Cell 
extract was pelleted at 16,000 g for 15 mins. Protein faction was harvested fronm 
the supernatant. Protein concentration was determined using Protein assay (Bio-
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Rad), according to manufacturer’s protocol. Bovine serum albumin protein 
standards (0 mg/ml, 1 mg/ml, 2 mg/ml, 4 mg/ml and 8 mg/ml) were used for the 
Protein assay.  Absorbance values of protein samples and standards were 
determined at 595 nm using Sunrise Microplate Reader (Tecan). 100 µg of 
protein was incubated in Laemmli buffer for 5 mins at 95˚C, and resolved by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (4% stacking and 
12% resolving gel) at 100 V for 1.5 hours. Resolved protein gel was transferred 
onto nitrocellulose membrane (Bio-Rad) in transfer buffer at 100 mA for 2 hours. 
Membrane was blocked in 5% skimmed-milk in TBST buffer for 1 hour at RT. 
Membrane was incubated in primary antibody overnight at 4˚C, washed thrice in 
TBST and incubated in horse radish perioxidase (HRP)-conjugated secondary 
antibody for 1 hour at RT. Membrane was washed thrice in TBST and 
chemiluminescence detection was performed using western blotting luminal 
reagent (Santa Cruz) according to manufacturer’s protocol. Primary antibodies 
used were rabbit-anti-HA (1:1000; SC805; Santa Cruz) and normalization control 
mouse-anti-β actin (1:2000; Invitrogen). Secondary antibodies used were HRP-
conjugated donkey-anti-rabbit and HRP-conjugated donkey-anti-mouse (1:2000; 
Invitrogen). 
 
7.9. Immunostaining and flowcytometry 
Cells were fixed in 4% paraformaldehyde for 30 min at RT, permeabilized with 
0.3% TritonX-100 for 5 mins at RT, and blocked with 1% BSA/5% FBS/PBS for 
30 mins at RT. Cells were incubated at RT for 2 hours in  1% BSA/5% FBS/PBS 
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with the following primary antibodies: Nestin (1:200; MAB353; Chemicon) and 
anti-Tuj1 antibody (1:500; MMS-435P; Covance) Cells were then incubated at RT 
for 1 hour with the corresponding secondary antibodies: Goat anti mouse IgG-
Alexa488 (1:500; Invitrogen), Goat anti-rabbit IgG-Alexa488 (1:500; Invitrogen), 
Goat anti-mouse IgG-Alexa594 (1:500; Invitrogen), and Goat anti-rabbit IgG-
Alexa594 (1:500; Invitrogen). Nuclei were counterstained with DAPI. Cells were 
analyzed using a Carl Zeiss fluorescence microscope. 
Quantitative analysis was performed by flow cytometry. 1x106 cells differentiated 
with N2B27 were dissociated from culture dishes into single cell suspension in 
accutase (Chemicon). Cells were fixed in 4% paraformaldehyde for 15 min at RT, 
permeabilized with 0.3% TritonX-100 for 5 mins at RT, and blocked with 1% 
BSA/5% FBS/PBS for 15 mins at RT. Cells were incubated at RT for 30 mins in 
1% BSA/5% FBS/PBS with the anti-Tuj1 antibody (1:100; MMS-435P; Covance), 
followed by Goat anti-rabbit IgG-Alexa488 (1:500; Invitrogen) at RT for 30 mins. 
Primary antibody incubation was omitted in the negative control. Cells were 
analyzed using BD FACSCalibur (Becton Dickinson). Paired t-test was used for 
statistical analysis. 
 
7.10. Embryonic stem cell maintenance 
E14 mouse ES cells were cultured without feeders on 0.1% gelatin-coated 
plates, in ES medium containing DMEM supplemented with 15% ES FBS 
(Invitrogen), 2 mM L-glutamine (Invitrogen), 0.1 mM MEM nonessential amino 
acid (Invitrogen), 0.1 mM -mercaptoethanol (Invitrogen), and Chinese hamster 
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ovary-Leukaemia Inhibitory Factor (CHO-LIF) (1000 U/ml) (Chemicon).  Medium 
was renewed every day and passaged with 0.05% trypsin every other day.  
Inducible-Zic3 clonal lines were previously generated (Lim et al., 2010). Cells 
were maintained in ES medium supplemented with 350 µg/ml G418 (Invitrogen). 
Medium was renewed every day and cells were passaged every other day with 
0.05% trypsin. To induce overexpression, inducible-Zic3 cells were treated with 
1.0 μg/mL doxycycline in mouse ES cell medium. 
 
7.11. Embryonic carcinoma cell maintenance 
P16CL6 embryonal carcinoma cells (Moore et al., 2004)  were cultured without 
feeders on 0.1% gelatin-coated plates, in embryonic carcinoma cell medium 
containing DMEM supplemented with 10% FBS (Invitrogen), 2 mM L-glutamine 
(Invitrogen), 0.1 mM MEM nonessential amino acid (Invitrogen) and 0.6 mg/ml 
geneticin. Medium was renewed every day. Cells were passaged with 0.05% 
trypsin (Invitrogen) every two to three days. 
 
7.12. Cardiomyocyte differentiation 
P19CL6 cells (Moore et al., 2004) were seeded onto 0.1% gelatin-coated dishes 
at a density of 4.2x103 cells/cm2 in differentiation medium containing DMEM 
supplemented with 10% FBS (Invitrogen), 2 mM L-glutamine  (Invitrogen), 0.1 
mM MEM nonessential amino acid (Invitrogen), 0.6 mg/ml G418 (Invitrogen) and 
1% DMSO. Medium was renewed every day for three weeks. Paired t-test was 
used for statistical analysis. 
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7.13. Neuronal differentiation 
ES cells were dissociated and seeded onto 0.1% gelatin-coated dishes at a 
density of 1x104 cells/cm2 in ES cell medium. 24 hours after seeding, ES cell 
medium was replaced with N2B27 medium containing 1:1 mixture of DMEM/F12 
(Invitrogen) and Neurobasal medium (Invitrogen). DMEM/F12 was supplemented 
with modified N2 (25 g/ml insulin, 100 g/ml apo-transferrin, 6 ng/ml 
progesterone, 16 g/ml putresine, 30 nM sodium selenite and 50 g/ml bovine 
serum albumin fraction V (Gibco), and Neurobasal medium was supplemented 
with B27 (Invitrogen). N2B27 medium was renewed every two days. For 
doxycycline induction in N2B27, N2B27 media was supplemented with 1 g/ml 
doxycyline. Fresh N2B27 supplemented with doxycycline was added to culture 
every day.  
 
7.14. Reprogramming assay 
Virus packaging cells, Plat-E (Morita et al., 2000),  grown to 70% confluency on 
15 cm2 dishes were transfected with pMX-Oct4, pMX-Sox2, pMX-Klf4 and pMX-
c-Myc (70 µg/construct) with Lipofectamine (90 µl; Invitrogen) according to 
manufacturer’s protocol. Transfection medium was removed 6 hours post 
transfection and replaced with MEF medium containing DMEM (Invitrogen) 
supplemented with 10% FBS (Invitrogen) and 2mM L-glutamine (Invitrogen).  
Virus-containing medium was collected at 24 and 48 hours after transfection. 
Virus-containing medium was filtered with 0.45 µm filter units (Millipore) and 
concentrated with 100 kDa concentration columns (Millipore) to a total volume of 
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500 µl. Oct4-GFP MEFs (Jackson Lab) were seeded at a density of 7.5x104 
cells/cm2 in MEF medium containing DMEM supplemented with 10% ES FBS 
(Invitrogen), 2 mM L-glutamine (Invitrogen). Six hours after seeding, cells were 
infected with the concentrated virus-containing medium (5 ul/cm2) in MEF 
medium supplemented with 5 µg/ml of protamine sulfate. Medium was replaced 
with fresh MEF medium 24 hours post-transfection. Inactivated-feeder MEFs 
were seeded on gelatin-coated plate at a density of 2.5x104 cells/cm2, in MEF 
medium. Two days post-infection, infected Oct4-GFP MEFs were trypsinized and 
plated on inactivated-feeder MEFs, in ES medium (refer to section 7.9). Medium 
was renewed every day and GFP-positive colonies were quantitated two weeks 
post-transduction. pMX-Oct4, pMX-Sox2, pMX-Klf4 and pMX-c-Myc as well as 
pMX-Zic3 constructs were previously generated (Feng et al., 2009; Lim, 2008). 
Paired t-test was used for statistical analysis. 
 
7.15. Zebrafish whole mount in situ hybridization 
Zic3-specific morpholino was generated based on a previous publication (Cast et 
al., 2012). 7.5 ng of morpholino was microinjected into zebrafish embryos at 1-2 
cell stages. Whole mount in situ hybridization on zebrafish embryos was 
performed using digoxygenin (DIG)-labeled riboprobes. Embryos were fixed in 
4% paraformaldehyde overnight at 24- and 48 hours post-fertilization. Fixed 
embryos were hand dechorionated and dehydrated in methanol at -20˚C 
overnight. Embryos were rehydrated stepwise in methanol/PBS and eventually 
stored in PBS containing 0.1% Tween 20 (PBST). Embryos were first incubated 
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in  hybridization buffer (50% formamide, 5x SSC, 50 µg/ml heparin, 500 µg/ml 
tRNA, 0.1% Tween20, 9 mM citric acid) at 70˚C for an hour, and hybridized to 
50-100 ng of probe at 70˚C overnight. Embryos were then washed in a series of 
buffer at 70˚C for 10 minutes each, in a stepwise fashion: 3 parts hybridization 
buffer and 1 part 2xSSC; 1 part hybridization buffer and 1 part 2xSSC; 1 part 
hybridization buffer and 3 parts 2xSSC; 2x SSC; 0.2x SSC (twice, 30 minutes 
each). Subsequent washes were performed at RT for 5 minutes each: 3 parts 
0.2x SSC and 1 part PBST; 1 part 0.2xSSC and 1 part PBST; 1 part 0.2xSSC 
and 3 parts PBST; PBST; PBST containing 2 mg/ml BSA and 2% sheep serum 
(1 hour). Embryos were then incubated with preabsorbed alkaline-phosphatase-
coupled anti-digoxigenin anti serum (1:5000) at 4˚C overnight. Embryos were 
washed six times in PBST at RT. Detection was performed in alkaline 
phosphatase reaction buffer. Reaction was stopped in PBS. Embryos were 
dehydrated, clarified in methylsalicylate and mounted in Permount. Images were 
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